6th International Symposium on Molecular Allergology (ISMA) by unknown
Clin Transl Allergy 2016, 6(Suppl 2):38
DOI 10.1186/s13601-016-0123-x
MEETING ABSTRACTS
6th International Symposium on Molecular 
Allergology (ISMA)
Lisbon, Portugal. 19–21 November 2015
ORAL ABSTRACTS
Symposium 1: Biochemistry, structure and environment of the 
allergen: what makes a protein an allergen?
O1 
Two cell‑membrane peptidases carrying 
galactose‑alpha‑1,3‑galactose are implicated in delayed 
anaphylactic reactions upon pork kidney ingestion in patients 
with IgE‑antibodies to alpha‑Gal
Christiane Hilger1, Kyra Swiontek1, Jörg Fischer2, François Hentges3, Chris‑
tiane Lehners3, Martine Morisset3, Bernadette Eberlein4, Tilo Biedermann4, 
Markus Ollert1  
1Luxembourg Institute of Health, Esch‑Sur‑Alzette, Luxembourg; 2Eber‑
hard Karls Universität, Tübingen, Germany; 3Centre Hospitalier, Luxem‑
bourg, Luxembourg; 4Technische Universität, München, Germany
Correspondence: Christiane Hilger
Clinical and Translational Allergy 2016, 6(Suppl 2):O1
Background: Delayed food anaphylaxis upon consumption of red 
meat is attributed to specific IgE-antibodies directed to galactose-α-
1,3-galactose (α-Gal). Anaphylactic reactions may occur after ingestion 
of meat from different mammals, mainly beef and pork, but reactions 
to lamb, rabbit or horse have also been reported. In particular, pork 
kidney has been shown to trigger symptoms that were more severe 
and occurred within a shorter delay.
The objective of the present study was the identification and charac-
terization of pork kidney proteins carrying α-Gal carbohydrates and 
mediating delayed allergic reactions through specific IgE to α-Gal.
Materials and methods: A cohort of 59 patients with specific IgE to 
α-Gal was screened by immunoblot for IgE-reactive proteins in pork 
kidney extract. Proteins were purified by affinity chromatography and 
identified by Edman sequencing and peptide mass fingerprinting. 
Isolated proteins were used in immunoassays using patient sera and 
α-Gal specific antibodies. Allergenicity was assayed in basophil activa-
tion and skin prick test.
Results: Multiple IgE-binding proteins were detected in protein 
extracts of pork kidney by immunoblot using patient sera and an 
anti-α-Gal antibody. Reactive bands were located in the high molecu-
lar weight range of 100 to ≥200 kDa. Two major IgE-binding proteins 
were identified as porcine angiotensin I converting enzyme (ACE I) 
and aminopeptidase N (AP-N). IgE-binding to both proteins was lost 
by periodate treatment, resulting in oxidation of carbohydrates. Addi-
tion of α-Gal inhibited IgE-reactivity to both peptidases. Allergenicity 
was confirmed by activation of patient basophils and positive skin 
prick tests.
Conclusions: Two IgE-reactive cell membrane peptidases carrying 
α-Gal epitopes were identified in pork kidney, a tissue which is known 
as potent inducer of red meat-induced anaphylaxis. Allergenicity 
and clinical relevance of these proteins were confirmed in patients 
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Background: Pollen of English plantain (Plantago lanceolata) has been 
associated with hay fever and asthma from late spring to autumn in 
temperate regions of the Northern hemisphere. Pla l 1, the major aller-
gen from plantain, is a glycoprotein which belongs to the Ole e 1-like 
protein family. Therefore, we set out to solve the structure of Pla l 1 
and compare its immunological properties with other allergenic Ole e 
1-like proteins.
Method: Recombinant Pla l 1.0101 was expressed as a non-glyco-
sylated and non-tagged protein in E. coli Rosetta-gami B pLysS. The 
protein was purified using cation exchange and size exclusion chroma-
tographies. Physico-chemical properties of the purified recombinant 
protein were analyzed using gel electrophoresis, circular dichroism 
(CD), dynamic light scattering (DLS) and Fourier transform infrared 
spectroscopy (FTIR). The 3-dimensional (3-D) structure was solved by 
X-ray crystallography. IgE-binding activity of Pla l 1 was investigated 
in ELISA and IgE cross-inhibition with Ole e 1, Fra e 1, Phl p 11, Che a 1, 
and Sal k 5 using sera from Austrian plantain pollen allergic patients.
Results: Pla l 1 was purified to a purity of >95 % and a yield of 24 mg 
per liter of culture. DLS revealed a hydrodynamic radius Rh of 2.04 nm, 
indicating that Pla l 1 is monomeric. CD spectrometry showed an unu-
sual spectrum with two negative minima and upon thermal dena-
turation a Tm of 68 °C was determined. FTIR analysis predicted a beta 
strand content of 40  %. X-ray crystallography revealed a barrel-like 
structure shaped by six antiparallel beta strands which is stabilized by 
three disulfide bonds. Structural modelling of all Ole e 1-like homo-
logues was consistent with a common fold, whereby highest structural 
similarity was observed with a cell wall surface anchor protein. Besides 
sensitization to Pla l 1, Austrian patients’ sera were also IgE-reactive to 
Fra e 1/Ole e 1 and Phl p 11. Notably, none of the homologs was able 
to substantially inhibit IgE binding to solid-phase Pla l 1.
Conclusions: Within this study we were able to solve the 3-D structure 
of Pla l 1 unravelling for the first time the Ole e 1-like fold. Although 
Ole e 1-like proteins share similar tertiary structures, IgE cross-reac-
tivity among non-phylogenetically related members was limited and 
consequently Pla l 1 should be regarded as marker allergen for primary 
Plantago sensitization.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
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Background: Allergy to pollen from short ragweed (Ambrosia arte-
misiifolia) is a severe and expanding health problem in Europe and 
Northern America. Amb a 1 has been so far the only major allergen 
characterized in ragweed pollen. Herein, we report on the identifica-
tion of Amb a 11 as a new major allergen, likely important for diagno-
sis and therapeutic purposes.
Materials and methods: Ragweed pollen proteins were submitted 
to high-resolution 2D gel electrophoresis and tested for IgE-reactivity 
using sera from 92 American or European ragweed-allergic donors. 
Pollen transcriptome sequencing, mass spectrometry (MS) and recom-
binant DNA technologies were applied to characterize new IgE-bind-
ing proteins.
Results: High-resolution IgE immunoblotting experiments revealed 
that 50 out of 92 ragweed-allergic patients were sensitized to a 
37 kDa-allergen distinct from Amb a 1. The full-length cDNA sequence 
for this molecule was obtained by PCR cloning, following MS sequenc-
ing combined with ragweed pollen RNA-Seq. This new allergen, 
termed Amb a 11 is a 262-amino acid thiol protease of the papain 
family, expressed as a combination of isoforms and glycoforms, follow-
ing proteolytic removal of N- and C-terminal pro-peptides from a pro-
form. X-ray crystallography confirmed a high structural homology with 
known cysteine proteases, such as the mite Der p 1 allergen. The pro-
tease activity of Amb a 11 as well as its capacity to activate basophils 
from ragweed allergic patients were documented. The recombinant 
pro-Amb a 11 zymogen was refolded in vitro from E. coli inclusion bod-
ies and matured at pH 5. This non glycosylated recombinant molecule 
was recognized by serum IgEs from 60  % of ragweed pollen-allergic 
patients.
Conclusions: We identified the cysteine protease Amb a 11 as a novel 
major allergen from ragweed pollen. Based on IgE reactivity docu-
mented in a majority of American and European patients, and given its 
cysteine protease activity, Amb a 11 should be considered as an essen-
tial component for diagnosis and specific immunotherapy of common 
ragweed allergy.
Keywords: Ragweed-pollen; Cysteine protease; New allergen
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Background: Polybia paulista is an aggressive social wasp found in 
Brazil. Many cases of allergy to Polybia paulista venom are reported but 
there is neither a diagnostic nor a treatment tool commercially avail-
able. Antigen 5 is shown to be a major allergen in other hymenoptera 
species playing an important role in cross-reactivity. Recombinant 
protein production of allergens allows interference-free diagnosis and 
treatment of patients as well as large scale production for commercial 
purposes.
Materials and methods: Mass spectrometry (MS) of natural venom 
was used for identification of antigen 5 from Polybia paulista. A gene 
optimized for E. coli expression was designed based on the amino 
acid sequence and a recombinant protein was produced in strain 
Rosetta-gami™ 2. Recombinant antigen 5 (rAg5) was purified by cat-
ion exchange chromatography. The primary sequence identity was 
analyzed by MS. Circular dichroism analysis was used to determine 
secondary structure composition and thermal denaturation. Molecu-
lar modeling was based on the crystal structure of the antigen 5 from 
Vespula vulgaris (PDB: 1QNX) using Expasy Swiss model tool. To test 
the stability, the protein was exposed to different temperatures rang-
ing from 25 to −80 °C up to 96 h. IgE reactivity was assessed using sera 
from twenty-two Brazilian patients allergic to wasp venom.
Results: A novel isoform of antigen 5 from Polybia paulista was identi-
fied by MS. A recombinant non-tagged folded Ag5 was expressed in E. 
coli in the soluble fraction. The intact mass was 23,192.41, with a delta 
mass of −8 corresponding to the disulphide bonds formation. The 
rAg5 CD spectrum is similar to antigen 5 homologs in other hymenop-
tera species being a mixture of alpha helix and beta sheets. The protein 
sequence of rAg5 is 59.11 % identical to Ves v 5 but at structure level 
the identity is 60.89  %. The rAg5 is very stable, not being degraded 
when exposed a 25  °C temperature. The allergen was recognized by 
IgE from 11 of 22 Polybia paulista venom allergic patients (50 %).
Conclusions: This is the first time that an E. coli expression system 
used for recombinant antigen 5 production resulted in properly folded 
and stable allergen. Recombinant Polybia paulista antigen 5 is a valu-
able diagnostic tool this allergy.
Keywords: Polybia paulista; Antigen 5; Hymenoptera venom; Venom 
allergy
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Background: Non-specific lipid transfer proteins (ns-LTPs) are an 
important cause of plant food allergy and symptoms range from 
mild to anaphylactic reactions. Pru p 3 (Prunus persica) is frequently 
described as the most recognized ns-LTP allergen. Diagnosis of ns-LTP 
related allergy is difficult, as patients frequently show an asympto-
matic ns-LTP sensitization.
Materials and methods: We included 2 peach allergic patients and 7 
peach tolerant patients, all of these patients showed sIgE reactivity to 
rPru p 3 (FEIA ImmunoCAP, Thermofisher Scientific, Sweden). Besides 
that a group of pollen allergic patients (n = 9) without Pru p 3 sensi-
tization and a healthy control group (n = 7) was included. Sera of all 
individuals were tested for sIgE reactivity to rPru p 3, rBet v 1, rArt v 1, 
rPhl p 1 and rPhl p 5b and a basophil activation test (BAT) with 4 con-
centrations of rPru p 3 was performed.
Results: Definite peach allergic patients showed a sIgE to rPru p 3 of 
6.11 and 0.44 kUa/L. The peach tolerant group with sIgE reactivity to 
the ns-LTP of peach demonstrated a median of 1.2 kUa/L (0.13–4.75). 
No sIgE antibodies to rPru p 3 were detected in the pollen allergic 
patients and the healthy control individuals. BAT with rPru p 3 was 
most discriminative at a concentration of 1  µg/ml. For this concen-
tration, both peach allergic patients showed a clear up-regulation 
of CD63. None of the Pru p 3 sensitized but peach tolerant individu-
als showed activation of their basophils. Neither the atopic patients 
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without Pru p 3 sensitization and control individuals showed an up-
regulation of CD63 on their basophils.
Conclusions: BAT with rPru p 3 might be a sensitive and specific test 
to document Pru p 3 induced peach allergy. Patient groups should be 
enlarged in order to further validate the basophil activation test with 
rPru p 3.
Keywords: Basophil activation test; Diagnosis; LTP; Peach
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Background: Quantification of allergen-specific IgE is challenging due 
to the low analytical sensitivity required and the need for accurate and 
reliable results. Today, this is mainly performed in diagnostic laborato-
ries, and therefore the delivery of results to allergists and patients takes 
often days. We have developed a nanofluidic-based biosensor contain-
ing a nanochannel that accelerates molecular interactions and thereby 
drastically reduces incubation time from hours to a few minutes. Several 
biosensors are assembled into one capsule which allows a multiple aller-
gen components-based in vitro diagnosis to be performed within one 
test. Capsules are then analyzed in the abioSCOPE, a miniaturized auto-
mated fluorescence microscope. Complexes of fluorescently labelled 
antibodies and allergen-specific IgE from a patient sample are specifi-
cally captured on the sensing area of the biosensors and, upon excita-
tion, emit fluorescence that is proportional to the analyte concentration.
Materials and methods: Capsules containing allergen-specific IgE 
tests were analyzed in the abioSCOPE to determine the analytical 
specificity of the tests and the potential effect of high total circulating 
IgE content on test results. Allergen-specific IgE levels from poly-sen-
sitized serum samples have been compared to concentrations meas-
ured in Phadia 250.
Results: High analytical specificity is indeed achieved as illustrated in 
a competitive inhibition study with Bet v 1 and Phl p 5a. Moreover, the 
test results are not influenced by high levels of total circulating IgE. 
Serum samples from poly-sensitized patients were analyzed in cap-
sules containing five key inhaled allergens of Central Europe (Bet v 1, 
Phl p 5a, Der p 1, Fel d 1, Can f 1). A good agreement was observed 
between allergen-specific IgE values measured in Phadia 250 and in 
the abioSCOPE.
Conclusions: Together, these results highlight the great potential of 
nanofluidic technology as a rapid, robust and easy-to-use method 
for the evaluation of patients suspected of having an allergic disease. 
Combining a component-based approach with patient history and 
in vivo skin tests allows allergists to provide their patients with a com-
prehensive diagnosis that supports the best medical decision within a 
single consultation.
Keywords: Components based diagnosis; Specific IgE; Quantification; 
Near-patient diagnostics; Nanofluidics
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Background: Allergen-specific immunotherapy (AIT) is the only cura-
tive therapy for allergy. However, little is known about the epitope 
diversity of antibody repertoires during AIT. Therefore, we aimed to 
monitor the development of the Bet v 1-specific IgE, IgG1 and IgG4 
repertoires in narrow time intervals during 3  years of subcutaneous 
birch pollen immunotherapy.
Materials and methods: In order to study antibody binding to con-
formational epitopes of the major birch pollen allergen, Bet v 1, four 
non-overlapping contiguous Bet v 1-specific surface areas were 
grafted onto Api g 1, the Bet v 1-homologue from celeriac. Sera from 
11 birch pollen-allergic patients with improved symptom and medica-
tion scores were collected before (time point 0) and after 1, 3, 6, 12, 18, 
24, 30 and 36 months of AIT. Antibody binding to Bet v 1, the four Bet 
v 1-specific areas on the chimeras and Api g 1 (scaffold protein) was 
assessed by ELISA.
Results: In the majority of the patients, Bet v 1-specific IgE-levels 
increased during the early phase of treatment followed by a gradual 
decrease. 7/11 patients (64  %) displayed slightly lower IgE-levels 
after 36  months of AIT compared to before therapy. Bet v 1-specific 
IgG4 was induced in all patients, whereas Bet v 1-specific IgG1 was 
induced in 7/11 patients. The IgG1 response increased earlier than 
IgG4 (P  =  0.016). The patterns of IgE-recognition of the four Bet v 
1-specific areas on the chimeras did not change over time in most 
patients. Similarly, once induced, the patterns of IgG1- and IgG4-
binding to the chimeras remained unchanged during AIT in 4/7 and 
8/11 patients, respectively. Furthermore, epitope profiles of IgE, IgG1 
and IgG4 differed among each other in the patients. IgE-binding to all 
four chimeras was observed in 7/11 (64 %) patients. In contrast, only 
two and three patients showed IgG1- or IgG4-binding to all chimeras, 
respectively.
Conclusions: Taken together, the repertoire of Bet v 1-specific IgE 
and induced IgG1 and IgG4 remained unchanged during AIT with IgE 
showing a higher diversity than IgG1 or IgG4. Therefore, not all IgE-
binding epitopes can be blocked by IgG4 or IgG1 due to direct epitope 
competition.
This study was supported by the Austrian Science Fund (FWF) grants 
SFB F4608 and F4610 and by the Christian Doppler Laboratory for 
Immunomodulation.
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Background: Polybia paulista is an aggressive social wasp, causing 
many accidents. Besides the importance of P. paulista allergy in Brazil, 
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there is neither a diagnostic nor a treatment tool commercially avail-
able. Hence Polistes sp. venom extract is used for skin tests and immu-
notherapy of Brazilian wasp venom allergic patients. The proximity of 
physicians and researchers in our group allows the use of ELISA and 
western blot analysis as a diagnosis support tool. Polistes venom is 
devoided of cross-reactive carbohydrate determinants (CCDs) allow-
ing CCD-free differential diagnosis of P. paulista allergy. The question 
regarding protection of Polybia allergic patients treated with Polistes 
venom extract in the immunotherapy remains unanswered.
Materials and methods: Twenty patients with clinical history of ana-
phylaxis to wasp venom were included and tested by ImmunoCAP® 
to Polistes(i4) and MUXF3 (o214). Skin prick (SPT) and intradermal test 
(ID) was performed using commercial Polistes venom extract. ELISA 
and western blot (WB) was made using commercial Polistes venom 
extract and Polybia venom extract produced by our group besides HRP 
ELISA for IgE anti-CCD detection.
Results: Patients presented clinical manifestations of anaphylaxis with 
symptoms that included urticaria, angioedema, diarrhea, respiratory 
symptoms and loss of consciousness. SPT was negative and the allergy 
was confirmed by ID test. In the IgE WB, all patients were positive to 
Polybia and Polistes recognizing multiple IgE-reactive bands different 
in each venom extract. In spite of this in IgE ELISA where the magni-
tude of IgE response to Polybia is 7 times higher than to Polistes only 
5 patients are positive for both venoms from those only 2 are positive 
for CCD. Results from ELISA, WB and CAP for Polistes are not coincident. 
Patients positive in CAP for Polistes are many times negative in ELISA.
Conclusions: Polistes venom extract is not suitable for diagnosis and 
treatment of Polybia patients as the sensitization pattern showed 
some differences. Despite the already reported cross-reactivity 
with homologs, possible new allergens unique in each venom were 
observed presenting distinct molecular masses not yet described. 
Conflicting results using extract goes along with previously reported 
problems in standardization of extracts used for diagnosis and treat-
ment. Recombinant production and characterization of the Polybia 
venom allergens would help to elucidate the diagnoses and allow 
proper therapy for P. paulista venom allergic patients.
Symposium 5: The advent of molecular allergology 
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Background: A rising prevalence of peanut allergy has been observed 
within the past decades. Routine diagnostic measures applying aque-
ous extracts (e.g. for skin prick test or IgE-detection measures) can lead 
to false negative results due to a lack of potential lipophilic allergens. 
Oleosins, a class of oil body proteins, have been found to be triggers of 
severe allergic reactions to hazelnut and sesame. Since data for peanut 
oleosins are scarce, the aims of the study were the isolation, the molec-
ular characterization and the assessment of the oleosin allergenicity. 
Moreover, we searched for a specific diagnostic approach to close the 
existing detection gap in the established peanut allergy diagnostics.
Materials and methods: A comprehensive oleosin isolation proce-
dure was established which comprises extraction and subsequent step 
by step purification of oil bodies along with preparative electropho-
resis. Protein identification was achieved by N-terminal sequencing, 
peptide mass fingerprinting and homology search against databases. 
The IgE-binding capacity of oleosins was evaluated in western blot 
experiments with sera of peanut-allergic, tolerant and non-allergic 
individuals. A flow cytometric basophil activation test was used for the 
diagnosis of oleosin-allergic patients.
Results: Oleosins were isolated and purified from the complex lipo-
philic matrix of peanut. Mass spectrometry analysis identified all 
known eight peanut oleosins, ranging from 15.5 to 17.5  kDa as well 
as further oil body related proteins (steroleosins and caleosins). 
IgE-binding to purified oleosins was observed in 20 of 39 sera from 
peanut-allergic patients by means of immunoblotting. Thus, oleosins 
meet the criteria to be classified as new allergens and isoallergens 
according to the WHO/IUIS allergen nomenclature subcommittee, and 
were accepted and designated as Ara h 14 and Ara h 15 in May 2015. 
Positive immunoblot results were observed solely in patients suffer-
ing from severe allergic reactions. IgE-dependent basophil activation 
was induced in vitro in a dose-dependent manner in peanut-allergic 
patients, but not in controls.
Conclusions: A novel strategy for the simultaneous isolation of the 
lipophilic peanut allergens oleosins was successfully established. The 
allergenicity of the distinct oleosins was illustrated by IgE-detection 
in immunoblot and confirmed by a functional cellular assay, the baso-
phil activation test. Oleosins proved to be relevant allergens that may 
cause more severe allergic reactions.
Keywords: Oleosins; Allergens; Isolation; Diagnosis
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Background: Oral allergy syndrome (OAS) is a common adverse reac-
tion to the ingestion of plant foods in patients with pollen-related 
allergic rhinoconjunctivitis. There is limited epidemiological informa-
tion on childhood OAS in regions with highly complex pollen expo-
sure. We aimed the present study to investigate OAS, its risk factors 
and underlying IgE sensitization patterns in children living in a Medi-
terranean country.
Materials and methods: This cross-sectional study assessed 1271 chil-
dren (age 4–17  years) with pollen-related seasonal allergic rhinocon-
junctivitis (SAR), enrolled by 16 Italian outpatient clinics. Data about 
OAS symptoms and their food triggers were acquired by a standard-
ized questionnaire. Skin prick tests (SPTs) were performed with com-
mercial pollen and food extracts. Specific IgE to the panallergens Phl 
p 12 (profilin), Bet v 1 (pathogenesis related protein class 10, PR-10) 
and Pru p 3 (non-specific lipid transfer protein, nsLTP) were tested by 
ImmunoCAP FEIA.
Results: Oral allergy syndrome was observed in 300/1271 (23.6  %) 
children with a prevalence increasing from age 5  year (24  %) to age 
16 year (37 %). Risk factors for OAS were a female gender (p < 0.001), 
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maternal OAS (p  <  0.001), living in the Northern Italy (p  <  0.05), and 
passive exposure to tobacco smoke (p < 0.01). OAS was strongly asso-
ciated with other SAR comorbidities: asthma (p < 0.001), anaphylaxis 
(p < 0.005), urticaria and/or angioedema (p < 0.001), atopic dermati-
tis (p < 0.001), and gastrointestinal symptoms (p < 0.001). IgE to one 
or more panallergens were found in 229/300 (76.3 %) of OAS affected 
children. Cucurbitaceae (melon and watermelon) were associated 
with IgE sensitization to Phl p 12; Rosaceae (apple, peach, pear) were 
strongly associated with IgE sensitization to Bet v 1; peanuts and tree 
nuts (hazelnut and walnut) were associated with IgE sensitization to 
Pru p 3. Kiwi’s allergy was the most frequent cause of OAS in children 
not sensitized to any of the three examined panallergens.
Conclusions: In a geographic area with complex pollen exposure, OAS 
is a highly frequent complication of childhood seasonal allergic rhini-
tis, even at preschool age. IgE sensitization to profilin, PR-10 and nsLTP 
explains most but not all of OAS childhood morbidity and kiwi allergy 
is the most important trigger. These results call for the inclusion of 
early diagnosis and OAS treatment in guidelines of pollen-related sea-
sonal allergic rhinitis in childhood.
Keywords: Oral allergy syndrome; Panallergens; Profilin; Lipid-transfer 
protein; PR-10
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Background: Amongst tree pollen allergies, birch is one of the main 
causes of winter and spring pollinosis in the temperate climate zone 
of the Northern hemisphere. This is caused by sensitization of patients 
towards Bet v 1, the major birch pollen allergen. Most of these patients 
not only suffer from rhinitis and asthma, but also develop adverse 
reactions towards various fruits, nuts, and vegetables—most fre-
quently against apple and hazelnut. These reactions are limited to the 
oral cavity and triggered by food proteins structurally related to Bet v 
1, as these allergens are also able to cross-link Bet v 1 specific IgE on 
mast cells and basophils. Therefore, we designed a hybrid molecule 
(MBC4) by assembling parts of Bet v 1 from birch, Mal d 1 from apple 
and Cor a 1 from hazelnut. For an increased safety profile, we intro-
duced a mutation into the backbone of MBC4 to reduce its IgE binding 
capacity.
Materials and methods: Parental allergens, as well as MBC4 were 
expressed in E. coli, purified to homogeneity and characterized phys-
ico-chemically. Sera from clinically diagnosed patients with birch pol-
len allergy and concomitant pollen-food syndrome towards apple and 
hazelnut were analyzed by IgE ELSIA and mediator release assay to 
determine the IgE binding capacity of MBC4. Additionally, we moni-
tored the immunological behavior in vivo in a mouse model.
Results: Significantly reduced IgE binding and allergenic effector 
function of MBC4 was observed by ELISA and mediator release assay, 
respectively. Analyses of patients´ sera revealed that the hybrid mol-
ecule showed a hypoallergenic factor of 10000 when compared to Bet 
v 1. Although IgE binding was reduced, MBC4 was able to induce cross-
reactive IgG antibodies to parental allergens in vivo, whereas murine IgE 
antibodies revealed a very limited cross-reactivity. Additionally, when 
splenocytes from mice where re-stimulated with either parental allergen 
or MBC4, a cross-reactive T cell response was observed in ELISpot assays.
Conclusions: As MBC4 revealed reduced IgE binding and allergic func-
tion in mice and man, and further was able to induce a cross-reactive T 
cell response as well as cross-reactive IgG antibodies, it presents itself 
as a suitable vaccine candidate to treat birch pollen and associated 
food allergies towards apple and hazelnut.
This work was supported by FWF L688 and ÖNB 12533 grants.
Keywords: Birch pollen allergy; Oral allergy syndrome; Allergen immu-
notherapy; Hybrid molecule
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Background: Up to 90  % of birch pollen allergic patients exhibit 
serum IgEs against Bet v 1, among which a majority reacts solely to 
this relevant allergen. Consequently, we produced a pharmaceutical 
grade recombinant Bet v 1.0101 molecule (rBet v 1) that was tested in 
patients via the sublingual route. Herein, we present some of the chal-
lenges faced during both the upstream and downstream pharmaceu-
tical and clinical developments of this molecule.
Materials and methods: Recombinant Bet v 1 was expressed in 
Escherichia coli at the 1500  L scale and further purified by multiple 
chromatographic steps. Characterization methods including elec-
trophoresis, liquid chromatography (LC), mass spectrometry (MS) or 
X-ray crystallography were decisive in order to identify and circumvent 
several issues related to the quality of the expressed or purified mol-
ecule. Safety and efficacy of rBet v 1 were assessed in a double-blind, 
placebo-controlled phase II study conducted in 483 european patients 
with allergic rhinoconjunctivitis to birch pollen.
Results: The LC-MS characterization confirmed the expected amino 
acid sequence with low levels of both deamidation and oxidation. 
Evidence for partially matured product was also documented. Moreo-
ver, in depth MS analysis revealed the presence of various amino acid 
substitutions. Both of those issues were solved by successive modifi-
cations of cell growth conditions. Despite multiple chromatographic 
steps and the absence of detection of host cell proteins (HCPs) by 
ELISA, MS characterization evidenced various HCPs that were removed 
through additional modifications of the downstream process. The later 
was further optimized since analyses showed the co-purification of a 
small molecule entrapped within Bet v 1 hydrophobic cavity, as con-
firmed by X-ray crystallography. Bet v 1 storage was modified in order 
to prevent its oxidation. Recombinant Bet v 1 tablets were evaluated 
in the first clinical study performed via the sublingual route with a 
recombinant molecule. Results confirmed that it is well tolerated by 
patients, with a level of efficacy consistent with the one observed with 
a birch pollen extract.
Conclusions: Even though Bet v 1 is a fairly simple molecule, its 
production as a recombinant biopharmaceutical product required 
extensive and iterative structural characterization as well as process 
optimizations in order to obtain GMP grade rBet v 1 for patients with 
birch pollen allergic rhinoconjunctivitis.
Keywords: Bet V 1; Birch pollen; Recombinant allergen; Sublingual 
immunotherapy
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Background: Lipid transfer proteins (LTP) are panallergens resist-
ant to heat and pepsin digestion, found in many plant-foods, as 
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fruits, vegetables, grains, peanut, tree nuts and also in pollens. It is a 
common cause of food-induced anaphylaxis (FIA) in adults living in 
Mediterranean area. LTP has also been proposed as a main cause of 
food-dependent exercise-induced anaphylaxis (FDEIA). We aimed to 
describe clinical characteristics and allergen sensitization profiles in 
patients with FIA related to LTP.
Materials and methods: Twenty eight patients were included [mean 
age 27.1 (SD ± 12.8) years, 29 % <18 years and 50 % male) with clinical 
history of FIA, whose allergological work-up confirmed sensitization to 
LTP. Patients were tested with a multiple plant-food and pollen panel 
and specific IgE to LTP allergens. LTP sensitization was assessed by in 
vivo (Pru p 3, LTP extract, Bial-Aristegui®) or by in vitro tests (specific 
IgE, ImmunoCAP / ISAC, ThermoFisher®).
Results: Median age of first anaphylactic episode was 26.5 [2-51] yrs; 
46 % had asthma; 68 % were atopic and 54 % had pollinosis (mugwort, 
wall pellitory, plane tree, olive and cypress). Co-sensitization to profil-
ins was found in 14 %. Overall in our center, LTP-induced anaphylaxis 
represents 15.7 % of all causes of FIA. Foods implicated in anaphylactic 
reactions were: Rosaceae fruits-36 % (peach and apple), tree nuts-29 % 
(walnut, cashew nut and hazelnut), seeds-25  % (sesame, sunflower 
seed and flaxseed) and other vegetables-21  % (peanut, green bean, 
goji berry, tomato and maize). In three cases the food implicated 
remained unidentified. Three patients had FDEIA (green bean, tree 
nuts, tomato and maize). Clinical manifestations were: mucocutaneous 
100 %, respiratory 86 %, cardiovascular 25 % and gastrointestinal 21 %. 
In 75  % the reaction occurred within the first 30 minutes after food 
ingestion; 29 % had ≥3 FIA before etiologic diagnosis.
Conclusions: LTP are important allergens of FIA in Portugal. LTP sensi-
tization is responsible for a heterogeneous group of offending plant-
foods, taxonomically unrelated, which can induce recurrent reactions. 
It is a useful risk marker in patients with severe reactions due to an 
unknown cause. The association of LTP-induced anaphylaxis with pol-
linosis is relevant in our country. The unpredictable clinical expression 
depends on the effect of cofactors such as exercise. The management 
of avoidance plans can be particularly challenging due to LTP be a 
widely cross-reacting allergens in plant-foods.
Keywords: Lipid transfer proteins; Panallergens; Anaphylaxis; Food 
allergy; Food-dependent exercise-induced anaphylaxis
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Background: There are few reports of allergic reactions to exotic fruits 
belonging to the Sapindaceae or Anacardiaceae plant families.
Materials and methods: We evaluated IgE sensitization profile in 
a 22-year-old woman with seasonal allergic rhinoconjunctivitis and 
history of food-dependent exercise-induced anaphylaxis to pista-
chio, anaphylaxis to lychee, mango and polyfloral bee polen dietary 
supplement. Skin prick testing (SPT) was performed with commer-
cial extracts, prick-prick testing with edible foods, serum specific IgE 
levels were determined by immunoblot test systems and fluorescent 
enzyme immunoassay (FEIA). Oral challenge tests were not performed 
due to clear history and ethical reasons.
Results: SPT revealed positive wheal reactions to Asteraceae pol-
len extracts of Ambrosia elatior (10  mm), Artemisia vulgaris (4  mm) 
and Helianthus annuus (5 mm). SPT with liquid extract of lychee (5 % 
purée of Litchi chinensis, fruit of the Sapindaceae family) was also posi-
tive (4 mm). Prick-to-prick tests with both Anacardiaceae native fruits 
were positive: mango (Mangifera indica) fruit pulp (5  mm) and pista-
chio (Pistacia vera) drupe seed (3 mm). Values of serum pollen-specific 
IgE by immunoblot were high for ragweed (79 kU/L, EAST class 5) and 
mugwort (4.6 kU/L, EAST class 3) pollen. Specific IgE to mango (<0.35 
kU/L, FEIA class 0) and lychee (<0.35 kU/L, EAST class 0) fruits were not 
detected. Molecular allergy assessment revealed involvement of profi-
lin in this particular phenotype of pollen-food allergy association, spe-
cific IgE to rBet v2 (3.2 kU/L, EAST class 2) being considered a profilin 
sensitization biomarker, homologous (hm) with mugwort Art v 4, rag-
weed Amb a 8, lychee Lit c 4 and mango Man i 3 profilins. IgE sensitiza-
tion to other tested allergen components was not found (<0.35 kU/L): 
rBet v 6 (isoflavone reductase hm with lychee Lit c IFR), rBet v 1 (pro-
tein hm with mango Man i 14 kD), rAra h 1 (7S vicilin hm with pistachio 
Pis v 3), rAra h 2 (2S albumin hm with pistachio Pis v 1), rAra h 3 (11S 
globulin hm with pistachio Pis v 2 and Pis v 5) and plant cross-reactive 
carbohydrate determinant (CCD).
Conclusions: In regions such as Southern Romania, where Asteraceae 
pollen sensitization is important, allergists must be aware of the 
potential role of cross-reactivity between mugwort and/or ragweed 
pollen and several exotic fruits, allergy risk of bee pollen supplements, 
and the role of in vivo and in vitro allergy testing, including compo-
nent-resolved diagnosis.
Consent: Written informed consent was obtained from the patient for 
publication of this abstract and any accompanying images.
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Background: We report the case of a 27-year-old man that started suf-
fering from recurrent episodes of anaphylaxis, following the ingestion 
of meals containing mixed foods. The first crisis occurred when he was 
20 years old, with generalized urticaria and angioedema, hypotension 
and blurred vision after ingestion of pizza.
Six months later another episode occurred after ingestion of meat-
balls and spaghetti. One year later, the same symptoms occurred with 
mixed food. Interestingly, all the systemic episodes developed 30-60 
minutes after exercise. Self-administered adrenaline was prescribed 
and the patient was advised not to exercise at least 2 hours after eat-
ing. Between the ages of 21 and 26 no more anaphylactic episodes 
were reported. This patient lost follow up. Two years later he was 
readmitted in our outpatient department after treatment in the emer-
gency room for exercise induced anaphylaxis. He also has complains of 
intermittent respiratory symptoms predominantly in the spring, since 
the age of 26.
Materials and methods: Skin prick tests (SPT) to commercial extracts 
of aeroallergens, foods allergens, Pru p 3 and profilin were carried out. 
Prick-to-prick tests (PP) and serum specific IgE determinations (sIgE) 
to airborne allergens and some plant foods were also performed, 
according to case history. Molecular diagnosis with ImunoCAP-ISAC 
and specific IgE determinations to some components were also per-
formed. Oral provocation tests (OPT) were performed to some of the 
suspected foods.
Results: Sensitisation to grass pollens, mugwort and multiple foods 
was demonstrated as shown in the Table 1 below. OPT to peach and 
pizza crust with exercise was negative.
Conclusions: In this patient with recurrent food-dependent exercise 
anaphylaxis the culprit allergen seems to be a non-specificLTP, as sIgE 
to Pru p 3 and Tri a 14 were positive and sIgE to ω-5-gliadin negative. 
Non-specific LTPs have been associated with cofactor-enhanced food-
dependent anaphylaxis in southern Europe. The variability of anaphy-
lactic reactions occurred in this patient could be explained by the type 
of exercise, food with different wheat processing and the season of the 
year.
Keywords: Anaphylaxis; Tri A 14; Wheat; Exercise
Consent: Written informed consent was obtained from the patient for 
publication of this abstract and any accompanying images.
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Background: Oral administration of iron salts for iron deficiency treat-
ment is usually well tolerated. Adverse gastrointestinal side effects 
are the most common. Exanthematous eruptions or anaphylactic 
reactions following a parenteral iron dextran injection or intravenous 
sucrose preparations are very uncommon
We report a case of anaphylactic reaction caused by intravenous 




A 71-years-old woman with a personal history of type 2 diabetes, dys-
lipidemia and iron deficiency anemia was referred to our department 
to be tested for a possible allergic reaction to iron salts. The patient 
reported that after starting the infusion immediately presents general-
ized micropapular urticarial reaction associated with intense feeling of 
heat and hypotension, so the infusion was stopped and treated with 
intramuscular methylprednisolone and dexchlorpheniramine. How-
ever she tolerate oral iron in ferrous form
Results: Skin tests were performed with FERIV® 20  mg/mL [sucrose 
and hydroxide iron (III)] and with excipients of the commercial for-
mulations. Positive responses were obtained in intradermal tests with 
FERIV® (1/1000 and 1/10,000). The excipients tested proved negative
Basophil activation test (BAT) were performed with FERIV® and FER-
ROCUR 40  mg [40  mg Fe3+] oral solution (tolerated by the patient). 
Positive responses were obtained in BAT with FERIV® (concentrations: 
10−1 and 10−2) and FERROCUR (concentration: 10−2). The excipients 
tested proved negative. BAT performed with FERIV® and FERROCUR in 
2 healthy controls were also negative
We could not perform an intradermal tests with FERROCUR because 
the patient had a multiple organ dysfunction syndrome and died
Conclusions: Iron salts are seldom responsible for allergic reactions. 
A few cases of eruptive dermatosis have been reported However, very 
few studies examine mild anaphylactic reactions or severe anaphylac-
tic reactions after intravenous administration.
The pathogenesis of anaphylactic reactions to iron dextran has not 
yet been elucidated. In most reports, these episodes occur after the 
first contact with the drug. This should support an anaphylactoid 
origin rather than a truly anaphylactic reaction. In our case, both the 
positive skin tests and the negative results in the control subjects 
tested corroborate the specificity of the response and demonstrate 
the existence of an immediate, possibly IgE-mediated hypersensitivity 
mechanism
Keywords: Intravenous iron salts; Anaphylaxis; Basophil activation test
Consent: Written informed consent was obtained from the patient for 
publication of this abstract and any accompanying images.
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Background: Many IgE-mediated food allergies in adults are caused 
by cross-reactivity between aeroallergens and food allergens. Pea-
nuts are not frequently involved in these pollen-food syndromes or 
associations.
Materials and methods: From adult patients with pollen-induced 
allergic rhinitis referred to our allergy clinic in one year-period, 
screened for suggestive history of allergy to Arachis hypogaea legume, 
we found only one 34-year-old female with moderate-severe persis-
tent allergic rhinoconjunctivitis, positive skin prick tests to five grass 
mix (6 mm wheal) and Artemisia vulgaris (5 mm wheal) pollen extracts, 
and convincing history of oral allergy syndrome to peanuts. Specific 
IgE sensitization pattern was assessed using multi-parameter immu-
noblot test system for defined partial allergen diagnosis.
Results: Serum specific IgE levels were found increased for Thimothy 
grass pollen (99 kU/L) and mugwort pollen (2.5 kU/L). IgE sensitization 
to single purified allergen components revealed genuine sensitization 
to Pooideae grass pollen: Phl p 1 (55 kU/L) and Phl p 5 (17.5 kU/L). Serum 
IgE to cross-reactive carbohydrate determinant marker was absent (<0.35 
kU/L), important in vitro assessment for excluding false positive IgE to 
peanuts in patients with grass pollen allergy. Specific IgE against plant 
cross-reactive allergen components, such as grass polcalcin (Phl p 7 cross-
reactive with weed Art v 5) and profilin (Phl p 12 cross-reactive with weed 
Art v 4), were not found. Low antibody serum titer of specific IgE to whole 
peanut extract was detected (0.7 kU/L). Serum specific IgE against peanut 
allergen components involved in early sensitization and systemic reac-
tions, the storage proteins rAra h 1 (7S vicilin), rAra h 2 (2S albumin) and 
rAra h 3 (glycinin legumin), and the nonspecific lipid transfer protein (LTP) 
involved in oral and/or systemic reactions rAra h 9, were not detected 
(<0.35 kU/L). IgE sensitization to defensins Art v 1, Ara h 12, Ara h 13 may 
explain cross-reactivity. In addition, specific IgE to Ara h 5 (profilin), Ara h 8 
(PR-10 Bet v 1-like protein), Ara h 10 and Ara h 11 (oleosins) were not avail-
able for component resolved diagnosis, but IgE to profilin biomarker rBet 
v 2 and PR-10 biomarker rBet v 1 were not detected (<0.35 kU/L).
Conclusions: A multiplex immunoblot assessment of single purified 
allergen peanut components can be used to determine the risk of sys-
temic reactions in selected patients with pollinosis and IgE sensitiza-
tion to peanuts.
Consent: Written informed consent was obtained from the patient for 
publication of this abstract and any accompanying images.
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Phleum pratense 4 5.91
Secale cereale 3.13
Artemisia vulgaris 6 17.2






Pru p 3 4 27.5 2.1
rTri a 14 19.9
rTri a 19 0.04
rPhl p 1 4.07 3.5
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Background: It was recently reported that red meat allergic patients 
have selective IgE responses to galactose-alpha-1,3-galactose (alpha-
gal) found in edible non-primate mammalian meat, and other com-
mon glycans reactive in allergic disease are not targets of such IgE.
Materials and methods: The serum of an adult male with recurrent 
episodes of delayed anaphylaxis and urticaria after ingestion of red 
meat (pork, beef and lamb), history of multiple tick bites and other 
arthropod exposure in a forest habitat from the Romanian Plain, with 
no history of rhinitis and/or asthma, assessed in vitro by ELISA for spe-
cific IgE to pork, beef and mutton meats, was evaluated for serum 
specific IgE against Pooideae subfamily grass pollen and Betulaceae 
family trees/shrubs pollen using an immunoblot system with the 
test kit containing strips coated with parallel lines of different pollen 
allergen extracts, and for serum specific IgE against single purified 
allergen components using a multiparameter immunoblot system for 
defined partial allergen diagnostics, both test kits assessing also IgE 
to cross-reactive carbohydrate determinant (CCD) marker of plant ori-
gin. Bromelain is a glycoprotein used for checking the cross-reactivity 
between a glycan and other glycoproteins since its MUXF3 carbohy-
drate chain is found in many plant proteins.
Results: This patient with delayed anaphylaxis to red meat and ele-
vated serum specific IgE levels against beef, pork and sheep meat, had 
negative skin prick tests to Betula and Pooideae pollen extracts, but 
elevated serum levels of specific IgE to pollen of sweet vernal grass 
(45 kU/L, EAST class 4), orchard grass (35 kU/L, EAST class 4), Timothy 
grass (41  kU/L, EAST class 4), cultivated rye (41  kU/L, EAST class 4), 
and birch (11.5 kU/L, EAST class 3). High levels of serum IgE to plant-
based CCD were evidenced (13.5 kU/L, EAST class 3), but serum IgE to 
recombinant non-glycosylated pollen specific allergen components: 
beta-expansin rPhl p 1, ribonuclease rPhl p 5, PR-10 protein rBet v 1, 
recombinant non-glycosylated pollen cross-reactive allergen compo-
nents: polcalcins rBet v 4 and rPhl p 7, profilins rBet v 2 and rPhl p12, 
and isoflavone reductase rBet v 6, were not detected (<0.35 kU/L, EAST 
class 0).
Conclusions: This is an isolated case of adult-onset delayed food 
allergy to red meat, in a patient with significant arthropod exposure, 
associated with serum IgE to plant-derived CCD.
Consent: Written informed consent was obtained from the patient for 
publication of this abstract and any accompanying images.
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Background: The immunological differences between atopic and 
non-atopic IgE-responses have been gathering increasing interest. 
Many researchers support that related research questions should also 
focus on other antibody isotypes and especially the IgG production. 
Our group has been studying IgG responses in atopics versus non-
atopics and preliminary results indicate that 2 year-old atopic children 
tend to develop slightly more frequently IgG responses to most envi-
ronmental allergenic molecules and sources. The aim of the study is to 
investigate the longitudinal trend of this immunological difference in 
IgG production observed in atopic and non-atopic children at 2 years 
of age.
Materials and methods: Children of the German Multicenter Allergy 
Study (MAS) were included in the present analysis if they had pro-
vided: (1) ≥1 serum sample at age 1–3 years, (2) ≥2 serum samples at 
ages 5–7 years, (3) a serum sample at age 10 years. IgG (cut-off ≥0.1 
ISU/L) and IgE (cut-off ≥0.3  ISU/L) to 91 molecules were tested by 
microarray (ISAC, TFS). Sera with undetectable IgE (<0.35 kU/L) against 
a panel of nine common foodborne and airborne allergenic extracts 
(ImmunoCAP, TFS) were considered negative for IgE against the panel 
of 91 molecules and were tested only for IgG. Atopy was defined as at 
least one positive IgE result against the panel of nine extracts.
Results: The mean prevalence of IgG production in non-atopics versus 
atopics was 41 and 47 % respectively (p value <0.001). Atopic children 
produced higher titers of IgG antibodies in comparison to non-atopic 
considering the geometric mean concentration (1.4 versus 1.1  kU/l, 
p = 0.013). This difference in the levels of IgG production was evident 
from the first year of life and remained up to the age of 10 years.
Conclusions: Atopic children produce longitudinally stronger and 
more frequent IgG responses in comparison to non-atopic in the MAS. 
Other factors such as nutritional aspects, the microbiome and/or 
parental history of atopy need to be taken into consideration to indi-
cate reasons explaining these differences.
Keywords: IgG; IgE; Components; Molecular; MAS
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Background: A significant increase of IgG (especially IgG4) anti-aller-
gen antibodies is significantly associated with the success of SIT. How-
ever, in non-allergic subjects, the presence of IgG specific for allergens 
is well documented, and their role is controversial.
Materials and methods: We studied the IgG anti-allergen antibodies 
in 142 allergic patients with food and/or respiratory allergy symptoms 
and 53 control subjects, clinically asymptomatic and free of IgE sensi-
tization, all living in the Southwest of France. After having determined 
the IgE sensitization profile by means of the ImmunoCAP ISAC™, we 
re-incubated the biochips with anti-human IgG polyclonal antibodies 
(Fc-specific) coupled to the AlexaFluor 647. The raw fluorescence val-
ues were converted to arbitrary units of IgG by means of a calibration 
serum having IgG reactivity toward 5 allergen components (nGal d3, 
rBla g 2, nArt v 3, nBos d lactoferrin, nGal d 1).
Results: We found that more than 80 % of individuals, allergic or not, 
have some IgG directed against egg white (nGal d1, d2), cow’s milk 
(nBos d5, d8), or one component from olive tree pollen (rOle e 9). For 
32 components, allergic patients have concentrations of specific IgG 
significantly higher than non-allergic individuals (p  <  0.001). Among 
the allergen components derived from the same organism, some are 
able to induce more frequently an IgE-sensitization, while other com-
ponents mainly induce an IgG response, regardless of the glycosyla-
tion of these components.
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Conclusions: Our results demonstrate that, in allergic patients, IgG 
sensitization is mostly directed against the same targets as that of 
IgE sensitization. This implies that, out of the context of SIT, IgG are 
most probably not able to protect allergic patients from IgE-mediated 
symptoms. In addition, we found that at least for some allergens (e.g. 
pollens from hazelnut, timothy-grass and olive tree), the selection of 
the immunoglobulin isotype during anti-allergen humoral responses 
is dependent on the allergen molecule itself (Table 2).
Undiluted sera from 195 individuals were studied by using the Immu-
noCAP ISAC™ biochip. After having been used to measure specific 
IgE concentrations, the same biochips were then re-incubated with 
polyclonal anti-human IgG antibodies conjugated to alexa fluor 647. 
For the determination of specific IgG concentrations, the raw fluores-
cence data were converted to arbitrary IgG units by using calibration 
curves established from the IgG reactivity of a control serum against 
5 components. Only allergen components for which IgG sensitization 
levels were significantly different between the sensitized/allergic and 
non-sensitized groups are shown. (a): group of 142 sensitized/aller-
gic patients (sum of IgE ISAC Specific Units against ImmunoCAP ISAC 
allergens is above 5 ISU-E) recruited for food and/or respiratory allergy; 
mean age 20 (range 1–56), sex ratio 0.79. (b): group of 53 non-sensi-
tized individuals, devoid of IgE-sensitization against any of the 112 
components present on the ImmunoCAP ISAC biochip; mean age 30 
(range 1–82), sex ratio 0.65. (c): IgG sensitization levels are expressed in 
arbitrary units (range 0–100 units). (d): p was calculated by the Mann–
Whitney non-parametric test.
Keywords: Specific IgG; Specific IgE; Allergen components; Biochip
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Background: The current paradigm claims that tolerance induced via 
regulatory T cells is the major mechanism to maintain a non-allergic 
status in healthy individuals. Here, we examine a new hypothesis, 
which postulates that also non-allergic individuals mount antigen-
specific immune responses against environmental antigens and that 
different immune response types exist and maintain this healthy con-
dition. Furthermore, we hypothesize that depending on the living 
environment, non-allergic immune responses can be different. Hence, 
we assessed the immune status of non-allergic people living in a farm-
ing environment, who are regularly exposed to the major grass pollen 
allergen Phl p 5 in the context of a diverse microbial environment (ani-
mal sheds, haylofts, harvesting activities) and non-allergic people liv-
ing in an urban environment, who lack such microbial exposure and 
diversity.
Materials and methods: Because of the low frequency of antigen-
specific memory T cells in non-allergic donors, peripheral blood mono-
nuclear cells were expanded antigen-specifically with rPhl p 5. After 
enrichment of antigen-specific memory T cells, proliferation markers, 
transcription factors, and cytokine secretion allowed identification 
of different T helper subsets like TH1, TH2, Treg, and TH17. Moreover, 
antigen-specific IgE, IgG1, IgG4, and IgA antibody levels in non-allergic 
humans were measured by ELISA.
Results: We could show that IFN-γ is the dominant cytokine after rPhl 
p 5 restimulation in non-allergic townspeople pointing to a TH1 biased 
immune response and we could also confirm this finding by staining 
of TH1 associated transcription factor T-bet. On the other hand, farm-
ers displayed similar numbers of IL-10 and IFN-γ producing cells and 
as well a balanced expression of transcription factors FoxP3 and T-bet. 
Additionally, we detected significantly higher Phl p 5-specific IgG1 
titers than IgG4 titers in both non-allergic groups. Interestingly, towns-
people showed significantly increased Phl p 5-specific IgG4 titers and 
IgG seroconversion compared to famers.
Conclusions: In summary, it can be stated that tolerance induction 
is not the only mechanism to maintain a non-allergic state but rather 
that diverse antigen-specific immune response types are common in 
non-allergic individuals. Multiple mechanisms of naturally acquired 
protection exist and depending on the living environment different 
immune response types can establish and maintain a healthy non-
allergic status.
Table 2 Compared to  non‑allergic individuals, aller‑
gic patients have higher concentrations of  specific IgG 















Egg white Food nGal d 2 19.54 11.25 <0.0001
Egg white Food nGal d 3 5.83 2.03 <0.0001
Cow’s milk Food nBos d 5 14.78 6.69 0.00019
Fish Food rGad c 1 3.35 0.12 <0.0001
Hazelnut Food nCor a 9 4.85 2.22 0.00011
Nut Food nJug r 2 6.51 1.61 <0.0001
Peanut Food rAra h 2 2.99 0.28 <0.0001
Peanut Food nAra h 6 3.61 0.15 <0.0001
Soy Food nGly m 5 3.22 0.57 <0.0001
Wheat Food rTri a 14 5.43 1.38 <0.0001
Wheat Food nTri a aA_TI 6.61 2.22 <0.0001
Bermuda Grass  
pollen
nCyn d 1 5.07 0.60 <0.0001
Timothy Grass  
pollen
rPhl p1 3.75 1.32 <0.0001
Timothy Grass pollen rPhl p 4 4.52 0.62 <0.0001
Cedar Tree pollen nCry j 1 2.76 0.39 <0.0001
Cypress Tree pollen nCup a 1 4.27 0.51 <0.0001
Plane tree Tree pollen nPla a 2 3.61 0.95 <0.0001
Cat Animal 
dander
rFel d 1 9.13 3.51 <0.0001
Dog Animal 
dander
rCan f 1 2.96 0.34 0.00027
D. farinae Mites nDer f 1 2.44 0.78 <0.0001
D. farinae Mites rDer f 2 4.87 0.06 <0.0001
D. pteron. Mites nDer p 1 1.10 0.08 0.00021
D. pteron. Mites rDer p 2 1.80 0.02 <0.0001
Dog Animal  
albumin
nCan f 3 3.51 1.13 0.00014
Peach LTP (food) rPru p 3 8.48 2.87 <0.0001
Mugwort LTP (weed 
poll)
nArt v 3 2.97 0.33 <0.0001
Plane tree LTP (tree poll) rPla a 3 3.97 0.30 <0.0001
Birch PR‑10 (tree 
poll)
rBet v 1 6.37 0.26 <0.0001
Hazelnut PR‑10 (food) rCor a 
1.0401
2.94 0.37 <0.0001
Apple PR‑10 (food) rMal d 1 4.42 0.44 <0.0001
Peach PR‑10 (food) rPru p 1 2.37 0.10 <0.0001
Latex Profilin rHev b 8 4.11 0.63 0.0003
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Background: The major ragweed pollen allergen Amb a 1 has been 
classified as member of the pectate lyase allergen family. To date, five 
different Amb a 1 isoforms have been officially acknowledged by the 
IUIS allergen nomenclature subcommittee. Moreover, pectate lyases 
have been identified as major allergens within the pollen of mugwort, 
a weed species which together with ragweed belongs to the botani-
cal order of Asteraceae, as well as within several trees belonging to the 
Cupressaceae order. Thus, we thought to investigate cross-reactivity 
pattern as well as sensitization profiles of Amb a 1 isoforms as well as 
related allergens from different sources.
Materials and methods: Pectate lyase pollen allergens from short 
ragweed (Amb a 1), mugwort (Art v 6), cypress (Cup a 1), mountain 
cedar (Jun a 1), and Japanese cedar (Cry j 1) were purified from aque-
ous pollen extracts. Moreover, three Amb a 1 isoforms (Amb a 1.01, 02, 
and 03, respectively) were either purified from pollen extracts or pro-
duced as recombinant proteins in P. pastoris. The allergens were char-
acterized physico-chemically and thereafter IgE binding was assayed 
by immunoblot, ELISA, cross-inhibition, and mediator release assays.
Results: For cross-reactivity profiling of Amb a 1 with homologous 
pectate lyases we found that each of the four cohorts included in the 
study showed a distinct sensitization fingerprint, which reflected the 
natural allergen exposure of the patients. Moreover, we analyzed the 
IgE binding to different Amb a 1 isoforms using sera of Amb a 1 sen-
sitized individuals from Central Europe. Within this cohort, we found 
that all three tested Amb a 1 isoforms were recognized by IgE to a simi-
lar extent.
Conclusions: Our data suggests that according to sensitization pro-
files pectate lyase allergens can be clustered into four categories, 
which are Amb a 1, Art v 6, Cup a 1/Jun a 1, and Cry j 1. Whereas 
cross-reactivity between Asteraceae and Cupressaceae allergens was 
limited, we found considerable cross-reactivity within each order. 
Moreover, there was no significant difference in IgE reactivity to the 
Amb a 1 isoforms 01, 02, and 03.
The work was supported by FWF project L688, CK-CARE AG Individual 
Project 2009-02, Biomay AG, the Christian Doppler Research Associa-
tion, and Sparkling Science SPA 05-193.
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Background: Lipid Transfer Proteins (LTP) are present in plant foods 
and aeroallergens. They cause sensitisation mostly by gastrointestinal 
system and besides being associated with Oral Allergy Syndrome 
(OAS), LTP sensitisation is mainly related with severe and systemic 
reactions.
Our objective was evaluate the frequency of LTP(Pru p 3) sensitization 
in patients referenced to our Immunoallergology Department and cor-
relate it with the pollens, latex and foods sensitisation and with the 
eventual relation with the severity of the allergic reactions.
Materials and methods: Retrospective observational study of 959 
patients referred to the Immunoallergology Department during a 
period of 9  months, which were submitted to a standard battery of 
Skin Prick Tests (SPT). The population was characterized according to 
demographic data, average SPT wheal diameter and type of clinic pre-
sented. Statistical analysis: SPSS v20.
Results: From the 959 patients (36 % Male, 64 % Female, Median Age: 
38 ± 18 years); 47 (5 %) presented LTP sensitisation. The patients were 
divided into two categories according to LTP sensitisation and char-
acterized (see Table  3). In the SPT, the average LTP wheal diameter 
in patients that presented allergic reaction to rosacea was 8.7  mm 
(OAS), 7  mm (OAS and Systemic Symptoms) and 8.7  mm (Systemic 
Symptoms). We confirmed a statistically significate (p  <  0.01) asso-
ciation between LTP and Pollen sensitisations, namely Grass, Cynodon 
Table 3 Characterization of the study population





 Female 64 % (30) 64 % (587)
Median age 34 ± 11 years 38 ± 18 years
Medical history
 Rhinitis 78.7 % (37) 74.3 % (678)
 Asthma 21.2 % (10) 28.3 % (259)
 Eczema 14.8 % (7) 11.5 % (105)
 Chronic Urticaria 14.8 % (7) 12.6 % (115)
 Symptoms with latex 6.3 % (3) 0.5 % (5)
Food allergy
 Fresh Fruits—Rosacea 31.9 % (15) 1.8 % (17)
 Fresh Fruits—Others 19.1 % (9) 2.3 % (21)
 Peanut 10.6 % (5) 0.6 % (6)
 Dry fruits 17.0 % (8) 0.9 % (9)
Clinic of Food Allergy to rosacea
 OAS 46.6 % (7) 58.8 % (10)
 OAS + Systemic 
Symptoms
20 % (3) 5.8 % (1)
 Systemic Symptoms 33.3 % (5) 35.2 % (6)
Pollen sensitization
 Wild Grasses 72.3 % (34) 32.6 % (298)
 Grasses Grown 70.2 % (33) 28.9 % (264)
 Cynodon dactylon 42.5 % (20) 14.5 % (133)
 Phleum pretense 63.8 % (30) 25.6 % (234)
 Plane tree 36.1 % (17) 5.5 % (51)
 Parietaria judaica 31.9 % (15) 8.4 % (77)
 Olive tree 57.4 % (27) 24.8 % (227)
 Artemisia vulgaris 29.7 % (14) 6.3 % (58)
 Plantago lanceolata 51.0 % (24) 19.7 % (180)
Latex sensitization 14.8 % (7) 2.4 % (22)
Profilin sensitization 10.6 % (5) 2.8 % (26)
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dactylon, Phleum pratense, Plane Tree, Parietaria judaica, Olive Tree, 
Artemisia vulgaris, Plantago lanceolata and Latex. We found that given 
a greater number of pollen sensitisation, the greater the amount of 
patients with LTP sensitisations (from 0 to 6 pollens: 1.8, 4.0, 4.1, 11.3, 
12.2, 22.7 and 41.7 % of sensitisation, respectively). There was no sig-
nificant association (p = 0.015, trust interval of 99 %) between LTP and 
Profilin(Pho d 2) sensitisations.
Conclusions: In the LTP sensitised patients, we verified a greater sensi-
tization to latex and foods, which occurred with a significantly greater 
frequency associated to rosacea fresh fruits. The LTP SPT wheal diam-
eter wasn’t higher in patients with a more severe symptomatology; the 
gravity of reactions was similar between both LTP sensitised and non-
sensitised patients. We also found a correlation between LTP and Pol-
len sensitisation (increase in the frequency of LTP sensitisation when 
the number of Pollen sensitisation is greater).
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Background: The reasons for the increasing number of patients suffer-
ing from allergic diseases are still not clear. In this study, we analyzed 
IgE-sensitization profiles, allergen exposure and lifestyle of 501 Aus-
trian pupils aged 13–21 in order to shed light on influencing factors in 
the development of allergic sensitizations.
Materials and methods: A randomized cohort of 501 Austrian pupils 
from three geographical regions (alpine, urban, rural) donated capil-
lary blood samples which were analyzed for IgE sensitization to 112 
single allergens using the ImmunoCAP ISAC. To examine the expo-
sure to indoor allergens from house dust mites, cats, dogs and molds, 
house dust samples were analyzed using a multiplex array. Demo-
graphic data, self-reported health status including allergies and other 
lifestyle conditions were collected using a detailed questionnaire.
Results: Fifty-seven percent of subjects declared to suffer from aller-
gies including self-reported adverse reactions, while 21  % stated to 
have clinically confirmed allergies. IgE reactivity to any of the 112 mol-
ecules on the ISAC chip was observed in 53 % of subjects. Highest sen-
sitizations were found to allergens from grass pollen (Phl p 1: 27  %), 
house dust mites (Der p 2/Der f 2: 18  %), tree pollen (Bet v 1: 16  %) 
and animal hair (Fel d 1: 14 %). The majority of subjects showed a com-
plex sensitization profile, while exclusive mono-sensitizations to insect 
venom, mites or grass pollen were found in 35 % of sensitized subjects. 
IgE reactivity to pollen allergens is mainly driven by sensitization to 
grass pollen allergens in this region. Fel d 1 and Can f 1 were the most 
abundant allergens in the collected house dust samples. The sensitiza-
tion rate to house dust mite was significantly higher in urban regions, 
whereas pupils in alpine regions were found to be less exposed to 
mite allergens which translated into lower IgE sensitization. Despite 
elevated levels of mite allergens found on farms, a decreased sensitiza-
tion rate to Der p 2 was found in pupils living on farms compared to 
those living in flats. Lifestyle factors, such as smoking and cat owner-
ship, as well as having allergic family members, showed a significant 
influence on the overall sensitization of individuals.
Conclusions: Distinct external triggers, such as living environment, 
dwelling form or allergen exposure, contribute to IgE development 
against distinct allergens and also to the onset of allergic diseases.
Supported by Sparkling Science, Federal Ministry of Science, Research 
and Economy, Austria.
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Background: The aim of our study was to assess the sensitization pat-
terns to perennial inhalant allergens by means of molecular diagnostic 
approach in the region of Pilsen, Czech Republic.
Materials and methods: The microarray system ImmunoCAP ISAC has 
been used for specific IgE detection to 112 different molecules. Sera 
from 779 patients sensitized to at least one perennial inhaled aller-
gen molecule were subject of analysis. These patients suffered from at 
least one of the following diagnoses: chronic rhinitis (73 %), bronchial 
asthma (41 %), atopic dermatitis (34 %), urticaria or angioedema (19 %) 
and/or anaphylaxis (11 %). Patient age ranged from 2 to 68 years, with 
a mean age of 25 years. The sex ratio was 45 % men to 55 % women.
Results: The most frequent sensitization rate was observed to cat-
derived molecules (53.4  % overall), the most frequent being Fel d 1 
(50.6  %). Sensitization to dog-derived molecules was slightly lower 
(38.4 % overall, Can f 5 26.0 % and Can f 1 22.1 %). The frequency of 
sensitization to at least an animal serum albumin (Fel d 2, Can f 3, Equ 
c 3, Bos d 6) was 6.6 %. This sensitization without sensitization to an 
animal species specific molecule was present only in 1.8 % of cases.
Almost the same sensitization rate as for cat was observed for mite-
derived molecules (52.7  % overall, group 2 43.2  %, group 1 32.4  %). 
Isolated sensitizations to molecules derived from storage mites Lep d 
2 and/or Blo t 5 without sensitization to other mite-derived molecules 
were observed only exceptionally (0.9  %). Similarly, sensitization to 
at least one cockroach specific molecule (Bla g 1, 2, 5) was very rare 
(in 1.0  %). Sensitization to a tropomyosin (Der p 10 and/or Bla g 7) 
was observed in 3.6 %. Co-sensitization of Der p 10 with other mite-
derived molecules was observed in 1.2 %.
The frequency of sensitization to mold-derived molecules was 33.4 %, 
the most frequent being Alt a 1 (26.8 %). Sensitization to Aspergillus 
derived molecules (Asp f 1 and/or Asp f 3 and/or Asp f 6) was 6.9 %.
Conclusions: Molecular diagnosis of allergy gives a more precise and 
comprehensive insight into perennial inhalant allergen sensitization 
patterns than extract-based testing, allowing for better understand-
ing of the sensitization process and regional differences. The data pre-
sented may help to improve the diagnostic and treatment procedures, 
especially focusing the need to quantify the content of the most fre-
quent sensitizing molecules in the diagnostic and therapeutic allergen 
extracts used in the respective region.
Keywords: Sensitization; Epidemiology; Perennial inhalant allergens; 
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Background: Recent studies have shown that the allergic IgE response 
to grass pollen starts years before disease onset as a weak monosensi-
tization or oligosensitization phenomenon and increase in serum con-
centration and complexity through a “molecular spreading” process 
during preclinical and early clinical disease stages. We aimed this study 
to investigate whether the development of the IgE response to house 
dust mite allergen molecules follows similar rules.
Materials and methods: We have taken advantage of the data of Mul-
ticenter Allergy Study, a prospective long-term observational birth 
cohort study, started in 1990 and recruiting 1314 infants born in 5 Ger-
man cities. Blood samples were collected at 1, 2, 3, 5, 6, 7, 10, 13 and 
20 years of age. Sera with IgE antibodies to an extract of Dermatopha-
goides pteronyssinus were further tested for the presence of IgE to Der 
p 1, Der p 2, Der p 4, Der p 5, Der p 7, Der p 11, Der p 14, Der p 15, Der 
p 18, Der p 21, Der p 23, Clone 16.
Results: Overall, 191 subjects with a IgE response to D.pt. at least once 
in life could be examined. The molecules most frequently recognized 
by IgE were Der p 2, Der p 1 and Der p 23, in 147, 117 and 97 subjects, 
respectively. The mean age at first detection of a positive response was 
inversely related to the frequency of detection to each individual mol-
ecule: respectively 8.7 (±0.70) (Der p 2), 8.9 (±0.85) (Der p 1) and 9.6 
(±0.98) (Der p 23). All the other allergens were detected in less than 
50 % of the cases. The profile of IgE sensitization to all the 12 exam-
ined allergenic molecules was extremely heterogeneous in the study 
population. Accordingly, 41 children responded to only one molecule 
during the whole observation period (monomolecular response), 67 
responded to 2–4 molecules (oligomolecular), and 60 responded to 
≥5 molecules (polymolecular). The maximum number of molecules 
recognized by IgE was inversely related to the age at first detection of 
an IgE response to D.pt.
Conclusions: Der p 1, Der p 2 and Der p 23 are the major allergenic 
molecules in the MAS birth cohort study. A molecular spreading in 
the IgE response was observed in most but not all mite-sensitized 
children, and the IgE response to mites is greatly heterogeneous at 
molecular level. Early sensitization is associated with polymolecular 
sensitization. The hypothesis that different sensitization profile and 
trends underlies different responses to AIT deserves to be tested.
Keywords: IgE antibodies; Childhood; Dermatophagoides 
pteronyssinus
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Background: Tropomyosin (Pen a 1) is a pan-allergen. The homology 
between tropomyosins from mites, crustaceans, molluscs, insects 
and nematodes is responsible for the cross-reactivity between them. 
Although Pen a 1 in vitro sensitization has been described, its in vivo 
sensitization has been poorly characterized.
Objectives: Study the prevalence of Pen a 1 sensitization by skin prick 
test (SPT) and its relation with a precise history of crustacean and/or 
molluscs allergy, in a population of patients with respiratory allergy 
sensitized to mites.
Materials and methods: Data regarding the 1030 patients followed 
during 9  months in an Allergy outpatient clinic were retrospectively 
analysed. Demographic and clinical information and the results of 
SPT—hospital standard panel for inhalants, shrimp extract and Pen a 
1 (Leti®) were collected. Positive result defined as a wheal diameter 
≥3 mm. Data analysis using STATA 13.
Results: There were included 450 patients with respiratory allergy 
(56  % rhinitis, 8  % asthma, 35  % both). All patients had sensitization 
to mites and were skin tested with a shrimp and Pen a 1 extracts. All 
the comparisons were made between patients with or without Pen a 
1 and shrimp extract sensitization. Pen a 1 SPT has higher specificity 
(96.67  %) and negative predictive value (41.67  %) in the confirma-
tion of clinical crustacean and/or molluscs allergy. On the other hand, 
shrimp extract showed a higher sensitivity (53.33  %). With regard to 
the degree of concordance between shrimp and Pen a 1 sensitization, 
the percentage of agreement were 90 % (majority of discordant pairs: 
shrimp+/tropomyosin−), Cohen’s kappa coefficient was 0.39 (moder-
ate concordance).
Conclusions: Although the percentage of Pen a 1 sensitized patients is 
small, these patients have higher cutaneous reactivity to mites (wheals 
with higher diameter). Pen a 1 sensitized patients have clinical history 
of crustacean and/or molluscs allergy more frequently than patients 
without Pen a 1 sensitization or with shrimp sensitization. The higher 
specificity of Pen a 1 SPT makes it an important tool for diagnostic con-
firmation of clinical allergy to crustacean and/or molluscs, in patients 
with respiratory allergy sensitized to mites.
Keywords: Tropomyosin; Skin prick test; Sensitization
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Background: Component-resolved diagnostics (CRD) is becoming of 
growing importance in clinical investigation of IgE-mediated allergies, 
which allows a comprehensive analysis of individual sensitization pro-
files with multiplexed purified and recombinant allergens. We studied 
the sensitization pattern in Georgian allergic patients.
Materials and methods: Allergic patient’s sera samples were tested 
by a microarray technology (ImmunoCAP ISAC, Thermo Fisher Scien-
tific, ImmunoDiagnostics, Uppsala, Sweden) and specific IgE levels 
against 112 different allergen components were detected.
Results: The study population, comprising 81 allergic patients, 
included 26 adults (mean age 36.2 ± 10.9) and 55 children (mean age 
6.1 ± 4.58). Polysensitization was seen in 84.6 % of subjects. Among 
investigated mainly species-specific food components IgE reactiv-
ity to nGal d 1, nGal d 2 and nBos d 8 was more prevalent and rep-
resented 11.3, 10.1 and 10.1 % correspondently. Concerning pollens, 
specific IgE antibodies against following aeroallergen components 
were detected more frequently: 1) grass pollen—nCyn d 1 (35.4  %), 
rPhl p 1 (35.4  %) and nPhl p 4 (34.1  %); 2) tree pollen—nCup a 1 
(26.5 %); 3) weed pollen—nAmb a 1 (21.5 %). Main allergen compo-
nent from the mold group was rAlt a 1 (10.1 %) and animal group was 
rFel d 1 (12.6 %). Among house dust allergen components sIgE to rDer 
f 2, nDer p 1 and rDer p 2 showed higher positive rates. PR-10 reactiv-
ity was detected in 56 patients (45 %), Profilin reactivity in 53 (43 %) 
and LTP in 36 (29 %).
Conclusions: The sensitization pattern specific for Georgian popula-
tion was defined by CRD, which helps to identify potential disease-
eliciting molecules, predict cross-reactivity, severity of reactions and 
the probability of the development of tolerance.
Keywords: Sensitization; Diagnostics; Allergen; Component
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Background: Cross reactivity syndrome is an increasing problem 
among allergic patients. Most commonly cross-reactivity appears 
between food and pollen. The aim of our study was to determine the 
most common food and pollen allergen cross reactivity in Lithuanian 
population.
Materials and methods: A retrospective study was conducted between 
2013 and 2014 in public institution “Centro Poliklinika”. Data of 510 
patients with suspicion of food or pollen allergy was analysed. We 
included 82 adults, age median 32 years [26–39], and 428 children, age 
median 5 years [4–8]. 262 (51.4 %) patients were men and 248 (48.6 %) 
women. All patients were tested with OPTIGEN® mix 36 panel (Hitachi 
Chemical Diagnostics, Inc. U.S.A) detecting allergen-specific immunoglobu-
lin E (IgE) for 36 food and inhalant allergens. A patient was considered aller-
gic if allergen specific immunoglobulin E (spIgE) was more than 2 class.
Results: We found a strong correlation between having food and 
pollen allergy (correlation coefficient 0.538, p  <  0.001). Very strong 
correlation was between nettle and orange (correlation coefficient 
0.914, p  <  0.001) and rape and tomato (correlation coefficient 0.738, 
p < 0.001). Strong correlation was found between mugwort and barley 
(correlation coefficient 0.662, p = 0.005), hazelnut and nettle (correla-
tion coefficient 0.638, p = 0.019) and between birch and apple (corre-
lation coefficient 0.636, p = <0.001).
Conclusions: We found very strong correlation between nettle and 
orange and rape and tomato in Lithuanian population. Also strong 
correlation was found between mugwort and barley, hazelnut and 
nettle and well known correlation between birch and apple.
Keywords: Cross reactivity; Food; Pollen
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Background: Sensitization to inhalant allergens is an increasing prob-
lem around the world as well as in Lithuania. The aim of this study was 
to evaluate the distribution patterns of allergy to inhalant allergens in 
the population of Lithuania.
Materials and methods: A retrospective study was conducted in 
2013–2014 year period in public institution “Centro Poliklinika” involv-
ing 664 patients of whom 49.5  % (n  =  329) were male and 50.5  % 
(n = 335)—female. Patients with suspicion of allergy to inhalants were 
tested for allergen—specific immunoglobulin E (IgE) using OPTIGEN® 
mix 36 and inhalant 36 panels (Hitachi Chemical Diagnostics, Inc. 
U.S.A). A patient was considered allergic when spIgE to an allergen was 
more than class 2.
Results: In our study 31.0  % (n  =  206) of participants were allergic 
to at least one inhalant allergen. 76.7 % (n = 158) of them were chil-
dren, age median was 5.0 [4.0–8.0] years, allergic adults encompassed 
23.3 % (n = 48), their age median was: 32.0 [26.0–39.0] years. 15.7 % 
(n = 104) of allergic patients were allergic to pollen. Among patients 
allergic to pollen, the most common allergens were timothy grass 
59.6 % (n = 62), birch 44.2 % (n = 46), mugwort 29.8 % (n = 31). 16.2 % 
(n = 111) of all allergic patients were allergic to house dust mites with 
no statistical differences between D. farinae and D. Pteronyssinus. The 
allergy to molds or epidermal allergens were less common.
Conclusions: In the population of Lithuania inhalant allergy was con-
firmed to one third of tested patients. Allergy to house dust mites and 
pollen were dominant. Timothy grass, mugwort and birch were the 
most important in pollen allergy.
Keywords: Inhalant; Allergens
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Background: Allergies due to the venoms of hymenoptera can cause 
severe systemic reactions. In spite of the progress of component-reso-
lution in the last years, diagnosis as well as therapy of venom allergy is 
still challenging. Amongst others this is due to extensive cross-reactiv-
ity between different venoms. In this study the antigens 5 of 7 hyme-
noptera species were recombinantly produced, characterized in detail 
and their cross-reactivity analyzed.
Materials and methods: The antigens 5 Ves v 5, Vesp c 5, Pol d 5, Pol 
a 5, Dol m 5, Sol i 3 and the potentially hypoallergenic Poly s 5 were 
recombinantly produced in insect cells. The resulting purified proteins 
were characterized by immunoblotting und structural models were 
generated. Moreover, sera of venom allergic patients were assessed 
for IgE cross-reactivity and additionally basophil activation tests were 
performed.
Results: All antigens 5 were successfully produced in Sf9 insect cells. 
As expected from sequence alignments structural models reveal iden-
tical folding, although surface charges differ between the different 
molecules. However, due to the use of Sf9 cells as expression host all 
antigens 5 were devoid of carbohydrate-based cross-reactivity. The 
analysis of sera from Ves v 5-reactive and Polistes allergic patients 
revealed extensive cross-reactivity of all antigens 5, independent of 
glycosylation. Some sera showed distinct reactivity profiles with the 
diverse antigens 5 and others reacted with all of them. Additionally, 
basophil activation tests from Ves v 5-reactive patients could reveal 
the same cross-reactivity with all antigens 5. This indicates the pres-
ence of shared as well as of individual IgE epitopes.
Conclusions: The comparative analysis of antigens 5 from 7 different 
hymenoptera species revealed extensive cross-reactivity between all 
allergens on protein level. This implicates that antigens 5 are inappro-
priate marker allergens for the diagnostic discrimination between anti-
gen 5-containing venoms. Moreover, detailed analyses on a molecular 
level can contribute to elucidate the clinical impact in the observed 
cross-reactivity.
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Background: Venoms of hymenoptera are responsible of 1/3 of ana-
phylactic shocks and 17 allergens have been described in the IUIS data 
bank in various hymenoptera species including Apis, Vespa, Vespula, 
Dolichovespula and Polistes. In 2004 a new sub species of Vespa, Vespa 
velutina, the yellow-leg asian hornet, was introduced in south west of 
France and is now present in more than 75 % of the French territory 
quickly progressing towards north and east of France. These hornets 
are bee-killers and build their nest close to human houses. Thus they 
represent a risk factor for biodiversity as well as for human health 
because their stings result in a huge loco-regional or systemic reac-
tion. Some anaphylactic shocks have been reported.
Materials and methods: In order to unravel the proteins and aller-
genic repertoire of the venom of asian hornet, an immunoproteomic 
study was designed.
Results: A protein extract from 20 venom sacs was performed and run 
in 1 or 2-dimensional (1 or 2D) gel electrophoresis. Western blotting 
using sera from patients diagnosed allergic to the venom of european 
hymenoptera (bees, yellow jackets or hornets) revealed numerous IgE 
reactive bands demonstrating that individuals, allergic to european 
hymenoptera venom, have IgE recognizing asian hornet venom pro-
teins. Mass spectrometry analysis of picked protein spots in 2D experi-
ments, followed by data bank searches, allowed the identification of 
allergens homologous to already known allergens in european hyme-
noptera venom (Vespa magnifica and affinis, Apis mellifera, Dolicho-
vespula maculata, Vespula vulgaris and germanica and Polybia paulista) 
such as phospholipase A1, antigen 5, arginine kinase, hyaluronidase 
and dipeptidyl di peptidase IV.
Conclusions: In conclusion the data show that some cross reactivi-
ties exist between European hymenoptera and asian hornet venom 
allergens. Whether specific unique allergens are present in the Vespa 
velutina venom is under investigation. The results will improve the 
diagnosis of allergy to hymenoptera venom and help in designing the 
appropriate extract for a specific immunotherapy of patient allergic to 
asian hornet.
Keywords: Hymenoptera asian hornet
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Background: Glycosylation plays an important role in the recogni-
tion and uptake of allergens by antigen presenting cells (APCs) and 
the modulation of immune responses. In addition, cross-reactive car-
bohydrate determinants (CCDs) constitute epitopes for human IgE, 
although their recognition seems not to be associated with clinical 
symptoms. Thus, elucidation of carbohydrate structures and investiga-
tion of their biological function is essential, to understand immuno-
logical properties of natural allergens.
Materials and methods: D. pteronyssinus and D. farinae extracts 
and natural house dust mite major allergens were assessed for the 
presence and identity of glycans by Periodate-Schiff staining, detec-
tion by c-type lectins, carbohydrate-specific antibodies and mass 
spectrometry.
Results: Glycan structures were detected by Periodate-schiff staining 
to be present on high molecular weight proteins in mite extracts from 
both species. Binding of the lectins GNA, PNA and DSA to many of 
these glycan-carrying proteins indicates the presence of N-linked high 
mannose and O-linked glycans comprising a core GalGalNAc1. Investi-
gation by a 1,3-fucose-specific antibody excluded the presence of the 
CCD 1,3-fucose in the investigated samples. Applying mass spectrom-
etry, the presence of various N-linked high mannose structures linked 
to a core HexNAc2 glycan was confirmed. Analyses of purified natural 
major group 1 and group 2 allergens showed that group 1 allergens 
from D. pteronyssinus and D. farinae can carry the N-glycans HexNAc1, 
HexNAc2 and HexHexNAc in a predicted N-glycosylation consensus 
sequence. Furthermore, our analyses demonstrate that group 2 aller-
gens from both species can carry at four homologous sites modifica-
tions by hexose monosaccharides and in addition at one of these 
residues a polyhexose.
Conclusions: Our results reveal a complex glycosylation pattern of 
proteins in D. pteronyssinus and D. farinae extracts that presumably 
influences significantly the allergenic and immunogenic properties 
of house dust mite proteins. The immunological relevance of the indi-
vidual identified carbohydrate modifications needs to be elucidated in 
detail in further studies. Our data could contribute to development of 
innovative approaches in allergen specific immunotherapy.
Keywords: Carbohydrate; Mite; Glycan; Allergen
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Background: Core structures of N-glycans modified with α1,3-fucose 
and β1,2-xylose represent the most frequently recognized IgE epitope. 
The lack of specific antibodies and the complexity of N-glycosyla-
tions so far hampered molecular insights into this important interac-
tion. Structural characteristics as well as fine specificity of antibodies 
against such carbohydrates remain largely unclear.
Materials and methods: Core glycan-specific IgE and Fab antibodies 
were produced by baculovirus-mediated infection of insect cells or 
in mammalian cells. Functionality and affinity of resulting antibodies 
was shown by ELISA and SPR analyses. Fab antibodies were used for 
crystallisation and structure determination in complex with an epitope 
disaccharide. Fine specificity and potential cross-reactivity with carbo-
hydrate antigens was assessed using glycan arrays.
Results: Recombinant IgE and Fab antibodies exhibited pronounced 
immunoreactivities in ELISA and dissociation constants in the 
nanomolar range. Structural analyses of a Fab in complex with the 
disaccharide epitope surrogate provided evidence for establishment 
of the IgE epitope by several antibody residues interacting with the 
core fucose. Glycan arrays that include a variety of synthetic carbohy-
drates representing the most frequently identified binding epitopes 
proved the specificity of the interaction of core-glycan-specific 
antibodies.
Conclusions: In summary, our data provide insights into the specificity 
of recognition of complex N-glycans in pathological conditions.
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Background: Many allergens are glycoproteins that carry one or sev-
eral carbohydrates linked to the protein structure. Not only proteins 
but also carbohydrates can stimulate the production of IgE antibodies 
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and be strong inducers of Th2 responses. Galactose-α-1,3-galactose 
(α-Gal) is a mammalian carbohydrate with significance in a novel type 
of food allergy. Patients with IgE against α-Gal report severe allergic 
symptoms 3 to 6 hours after red meat consumption. We investigated 
whether IgE from red meat allergic patients recognize other mamma-
lian glycans than α-Gal or glycans from the plant kingdom and ven-
oms of importance in allergy. Furthermore, we examined whether red 
meat allergic patients’ IgE response is directed against the carbohy-
drate-protein complex or against the glycan part only.
Materials and methods: Sera from 24 red meat allergic patients 
were analyzed on ImmunoCAP for IgE against α-Gal, MUXF3, nCup 
a 1, nArt v 1 and with Streptavidin ImmunoCAP for biotinylated-Gal-
α1,3-Gal, biotinylated-Neu5Gc, as well as enzymatically deglycosylated 
biotinylated-Gal-α1,3-Gal. The absence of the α-Gal epitope after 
enzymatic deglycosylation was identified and verified by an anti-α-
Gal monoclonal antibody, IgE from red meat allergic patients by IgE-
immunoblot as well as α-Gal-IgE inhibition experiment.
Results: We found that all 24 red meat allergic patients neither had 
an IgE antibody response against the other abundant mammalian 
glycan N-glycolylneuraminic acid nor against cross-reactive carbohy-
drate determinants from plant or venom sources (nCup a 1, nArt v 1 
and MUXF3). Deglycosylation of an α-Gal containing protein, bovine 
thyroglobulin, significantly reduced the IgE response.
Conclusions: We show that red meat allergic patients have a selective 
IgE response to the α-Gal glycan found in red meat. Other common 
glycans reactive in allergic disease are not targets of red meat allergic 
patients’ IgE.
Keywords: a-Gal; Cross-reactive carbohydrate determinant (CCD); Gly-
can; IgE; Red meat allergy
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Background: Plant non-specific lipid transfer proteins (nsLTPs) are 
relevant food allergens e.g. from peach (Pru p 3), hazelnut (Cor a 8) or 
walnut (Jug r 3). They share a conserved fold with an internal cavity. 
Different lipid–protein complexes showed that the tunnel adapts its 
volume while binding a broad range of hydrophobic molecules.
Materials and methods: The probe 1-anilinonaphthalene-8-sulfonic 
acid (1,8-ANS) is non-fluorescent in water but fluorescent with a maxi-
mum emission wavelength at 456 nm when binding to the hydropho-
bic cavity of nsLTPs. Pru p 3, Cor a 8 and Jug r 3 were incubated with 
different fatty acids (lauric, stearic, oleic acid) and total lipid extract 
from hazelnut. The binding of lipids was monitored by adding 10 µM 
1,8-ANS and measuring the decrease of 1,8-ANS fluorescence. Further-
more, molecular dynamic (MD) analysis was applied to explore the 
nature of interaction between nsLTPs and tested ligands. ptraj analysis 
was used to process MD trajectories and to provide information about 
RMS deviation from a reference structure, hydrogen bonding, time-
correlation functions and diffusional behavior.
Results: Due to pre-incubation of Pru p 3 with lipids a concentration 
dependent reduction of ANS binding was observed. Pru p 3 incubated 
(1:1; 1:10) with lauric acid showed 19 and 66  % of ANS fluorescence 
reduction, respectively, compared with Pru p 3 without lipids. For oleic 
acid (1:1; 1:10) reduction was 7 and 77 %, respectively. For other tested 
lipids and nsLTPs, this reduction was not seen. Molecular dynamic 
analysis suggests changes in protein structure due to binding of cer-
tain ligands. Interaction of Pru p 3 with oleic acid moved the C-ter-
minal loop out towards the surface of the molecule. This interaction 
is stabilized by hydrogen bonds with Arg32. Interestingly, the region 
affected by conformational changes is one that was shown to be one 
of the main epitopes of Pru p 3.
Conclusions: In this study, we observed that Pru p 3 was able to bind 
lauric and oleic acid, while other lipids did not interact. Molecular 
dynamic simulation has proved differences in the binding capacity of 
Pru p 3 with the ligands that can lead to conformational changes. The 
allergen–lipid interaction may act as a potential danger signal during 
the allergic sensitization phase or increase allergenicity during the 
effector phase. However, this remains to be investigated.
Keywords: Non-specific lipid transfer proteins; Protein–ligand interac-
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Background: Food allergy to sweet cherry is very common through-
out Europe. Oral reactions observed in people from central and 
northern parts of Europe are mainly caused by Pru av 1 (Bet v 1-like) 
allergens, whereas systemic reactions, more common in the Mediter-
ranean region, are caused by the Pru av 3 (nsLTP) allergen. Hypoal-
lergenic cherry cultivars might be identified by analysing gene 
expression levels of Pru av 1 and its isoallergens or variants, and Pru av 
3 in natural occurring cherry cultivar variations. However, no RT-qPCR 
assays are available so far. Therefore, we designed different RT-qPCR 
primer sets for Pru av 1 and Pru av 3 gene expression studies.
Materials and methods: Coding sequences of Pru av 1.0101, three Pru 
av 1.02 variants, and the Pru av 3 coding sequence were cloned in a 
pET16b vector. Constructs were verified by sequencing, and plasmid 
DNA was isolated. Primer sets were validated for specificity using dif-
ferent plasmid DNA samples with real-time quantitative PCR experi-
ments using SybrGreen I chemistry on a LightCycler 48 instrument.
Results: PCR amplification curves were obtained using the designed 
primer sets. Primer set 1 showed specific amplification of isoallergen 
Pru av 1.0101. Primer set 2 amplified the three variants of isoallergens 
Pru av 1.02 (i.e. Pru av 1.0201, Pru av 1.0202 and Pru av 1.0203). How-
ever, this primer set did not amplify Pru av 1.0101. All tested Pru av 1 
sequences were amplified simultaneously using primer set 3. Finally, 
primer set 4 specifically detected Pru av 3.
Conclusions: Four novel real-time PCR primer sets have been 
designed which can be used in RT-qPCR experiments to detect Pru av 
3 and Pru av 1 sequences. In the future, this could lead to the identifi-
cation of natural hypoallergenic cherry cultivars.
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Background: Fresh cherries can cause oral allergy symptoms in patients 
with birch pollinosis due to the cross reactivity of IgE to the birch pol-
len Bet v 1-homologous cherry protein Pru av 1. Previously, different Pru 
av 1 isoallergens and variants have been identified. These isoallergens 
showed diverging IgE-binding properties and therefore need to be 
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taken into account when analyzing Pru av 1 protein expression levels in 
cherry cultivars. Therefore, we determined the specificity of anti-Pru av 1 
monoclonal antibodies using Western blot analysis and ELISA.
Materials and methods: Coding sequences of Pru av 1.0101 and three 
Pru av 1.02 variants were cloned in a pET16b vector and transformed 
into E. coli strain BL21(DE3). Pru av 1 expression was induced and the 
presence of the four allergens in bacterial lysates was verified using 
LC–MS–MS analysis. Three anti-Pru av 1 monoclonal antibodies (F11, 
G4A, and G4D) and 1 polyclonal, the Pru av 1 cross reactive anti-Cor a1 
antibody, were used in Western blot analysis of the bacterial lysates. 
Finally, specificity of a sandwich ELISA was determined using the F11 
anti-Pru av 1 monoclonal antibody as catching antibody and the anti-
Cor a 1 antibody as detecting antibody.
Results: Western blot analysis showed that the cross reactive anti-Cor 
a 1 antibody was capable of detecting all Pru av 1 proteins. The F11 
monoclonal antibody strongly detected the Pru av 1.0101 protein but 
also had weak affinity for the other Pru av 1.02 variants. Monoclonal 
antibodies G4A and G4D were specific for isoallergen Pru av 1.0101. 
Sandwich ELISA using antibody F11 in combination with anti-Cor a 1 
antibody easily identified the Pru av 1.0101 isoallergen. Pru av 1.0201 
was only detected at high concentrations while the other Pru av 1.02 
variants could not be identified using the ELISA.
Conclusions: The tested anti-Pru av 1 monoclonal antibodies can be 
used to specifically detect and quantify isoallergen Pru av 1.0101 in a 
sandwich ELISA.
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Background: Improving production yield and elevating quality of 
recombinantly produced molecules is a high priority for the biotech-
nological as well as for the clinical sector. This issue has been tackled 
from numerous angles, one of them being codon usage bias. Crucial 
information concerning the overall protein synthesis procedure is 
encoded by the codon usage frequency; and hence even single synon-
ymous codon mutations can significantly affect gene expression levels 
along with protein folding and function. Suboptimal codon usage bias 
can significantly limit heterologous protein expression. “Codon harmo-
nization” is a strategy that effectively minimizes codon usage dispari-
ties between native and heterologous host by closely matching their 
respective codon usage frequencies. In this study we investigated the 
effects of codon harmonization in the recombinant production of the 
allergen Bet v 1.0101.
Materials and methods: Different batches of rBet v 1 and its harmo-
nized version, Bet-Harm, were produced in parallel. Production yields 
were quantified by SDS-PAGE densitometry. All batches were phys-
icochemically analyzed by mass spectrometry, amino acid analysis, 
circular dichroism, dynamic light scattering, Fourier transform infrared 
spectroscopy and ANS-binding assays. Immunological properties of 
the rBet v 1 and Bet-Harm batches were compared by endolysosomal 
degradation assays, ELISA and mediator release assays.
Results: A significant increase in protein yield and solubility was 
observed for Bet-Harm compared to rBet v 1. Besides, the two proteins 
displayed no alterations in their secondary structure elements, their 
behavior in solution and their ligand-binding ability. Furthermore, no 
differences in the proteolytic susceptibility, IgE-binding and IgE cross-
linking ability of rBet v 1 and Bet-Harm were observed.
Conclusions: Codon harmonization is an effective approach towards 
increasing protein expression levels and should be considered as a 
potent strategy for overcoming protein production problems.
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Background: Pathogenesis-related (PR) proteins are encoded by dif-
ferent genes that are induced to defend the plants against infections 
with fungi, bacteria or viruses. The exact function of the PR proteins 
of class 10 is still unclear. Most of the identified plant allergens can 
be grouped into the PR-10 protein family. A prominent member of 
this protein family is Bet v 1 (Betula verrucosa), the birch pollen aller-
gen. Bet v 1 proteins represent one of the best-characterized group of 
model allergens in immunology. These proteins are one of the main 
causes of allergic reactions worldwide, with an estimated 100 million 
people affected. More than 70 % of birch pollen allergic patients are 
also reacting allergic to apple. Mal d 1 (Malus domestica) is the main 
allergen found in apples. The cross-reaction between Bet v 1 and Mal d 
1 may result from a high degree of amino acid sequence identity (55–
68 %) and the structural similarity of these two proteins.
Materials and methods: The goal of our study is to characterize and 
compare the structures, the stabilities and the flexibilities of allergenic 
PR-10 proteins from various sources (i.e. birch pollen and apple) by dif-
ferent NMR spectroscopic techniques.
Results: We rationalize the different allergenic and immunological 
properties of Bet v 1 and Mal d 1 and obtain structural insight into the 
cross-reactivity of these two allergens. Our data provide a comprehen-
sive picture of the interplay between structure, dynamics and function 
of different allergens from the PR-10 family.
Conclusions: Among the factors that can contribute to the allergenic 
potential of proteins, we hypothesize that intrinsic dynamic and struc-
tural processes are not only critical but even essential for their immu-
nologic properties.
Keywords: Bet V 1; Mal D 1; NMR spectroscopy
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Background: Polcalcins are small calcium-binding pollen proteins 
(around 9  kDa). They have been identified in pollen from diverse 
plant families where they are considered minor allergens. Due to their 
sequence homology and conserved structure, they show a high cross-
reactivity. Polcalcins are not usually as much represented as other 
allergens in pollen extracts, for that reason their availability as purified 
proteins would represent an useful tool for diagnosis and/or immuno-
therapy purposes in allergic individuals.
The objective of this study was to purify the native polcalcin from dif-
ferent pollen allergenic sources by developing a purification method 
based on affinity chromatography.
Materials and methods: RNA from Chenopodium album pollen was 
obtained and used in RT-PCR with specific primers to obtain the polcal-
cin (Che a 3) cDNA. This cDNA was cloned in pQE31 vector and the pro-
tein expressed in Escherichia coli. The recombinant protein was purified 
by affinity chromatography and size exclusion filtration, characterized 
by immunoblot and sequencing and used to produce rabbit polyclonal 
antibodies. These antibodies anti-rChe a 3 were also purified and used to 
identify polcalcin in different pollen extracts by direct ELISA. An anti-rChe 
a 3 antibody-sepharose column was packed for the purification of polcal-
cin from C. album and Olea europaea extracts.
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Results: The RT-PCR allowed the obtaining of a 261 pb cDNA which 
sequence corresponded to Che a 3. A highly purified 10 kDa-protein 
was obtained after its expression and purification in two steps and its 
identity confirmed as Che a 3. Polcalcin was detected by ELISA in eight 
pollen extracts including Cynodon dactylon, C. album, Phleum prat-
ense, O. europaea, Alnus glutinosa, Anthoxantum odoratum, Parietaria 
judaica, and Betula alba. Extracts from O. europaea and C. album were 
selected for the purification of native polcalcin. Purified Che a 3 and 
Ole e 3 were obtained with a high degree of purity (>95  %). Ole e 3 
was identified by mass-spectrometry.
Conclusions: Affinity chromatography based on specific antibodies is 
an efficient Materials and methods for the purification of native pol-
calcin from different allergenic sources.
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Background: Wheat is an important part of the daily diet of millions of 
people; however, this staple food is also responsible for food allergies. 
Food allergy has become a major health issue in developed countries, 
therefore there is an urgent need to develop analytical methods able 
to detect and quantify with a good sensitivity and reliability some spe-
cific allergens in complex food matrices.
Wheat genus presents species with different ploidy levels, among 
which: diploid species with genome A (T. monococcum, einkorn); tetra-
ploid with genomes A and B (durum wheat, Emmer); and hexaploid 
with genomes A, B and D (spelt, bread wheat). The bread wheat cur-
rently cultivated (T. aestivum) is hexaploid (genome ABD). It originated 
through spontaneous hybridizations between A, B and D genome of 
ancestral species and has been widely bred. In the case of prolamins, 
there is experimental evidence for a natural variation in the degree of 
biological activity between cereal genus (oat, rye, barley and wheat) as 
well as in the genus Triticum.
T. monococcum, is an ancient species which has received renewed 
attention in the context of low impact and sustainable agriculture and 
because of its potential nutritional qualities. In addition, it was shown 
to exhibit a lower IgE-binding capacity compared to hexaploid spe-
cies. We present a targeted MS/MS approach to compare the relative 
abundance of the major recognized wheat allergens in the salt-soluble 
(albumin/globulin) fraction of wheat grains.
Twelve allergens were quantified in seven wheat varieties, selected 
from three Triticum species: species: T. aestivum (bread wheat), T. 
durum (durum wheat), and T. monococcum.
Materials and methods: The allergens were monitored from one or 
two proteotypic peptides and their relative abundance was deduced 
from the intensity of one fragment measured in MS/MS.
Results: Whereas the abundance of some of the targeted allergens 
was quite stable across the genotypes, others like alpha-amylase 
inhibitors showed clear differences according to the wheat species, in 
accordance with the results of earlier functional studies.
Conclusions: This study enriches the scarce knowledge available on 
allergens content in wheat genotypes, and brings new perspectives 
for food safety and plant breeding.
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Background: Defensin-like proteins such as Art v 1, the major allergen 
from mugwort (Artemisia vulgaris), Amb a 4 from ragweed (Ambrosia 
artemisiifolia) and Par h 1 from feverfew (Parthenium hysterophorus) 
are important triggers of allergy. They consist of an N-terminal globular 
domain and a C-terminal proline-rich extended tail. To investigate the 
structural and immunological features of these proteins, Art v 1, Amb a 4 
and Par h 1 were expressed in E. coli and purified to homogeneity.
Materials and methods: Proteins were characterized using mass 
spectrometry, dynamic light scattering, circular dichroism and Fou-
rier transform infrared spectroscopy. For immunological studies the 
proteins were subjected to endolysosomal degradation and in vitro 
antigen uptake with BMDCs. IgE recognition and cross-inhibition 
experiments were assessed by ELISA using patients’ sera from Austria 
(n = 40), Canada (n = 38) and Korea (n = 27). The allergenic activity 
was studied by mediator release assay.
Results: The identity of purified proteins was confirmed by mass 
spectrometry. The three proteins were monomeric as determined 
by dynamic light scattering. Fourier transform infrared spectroscopy 
revealed comparable content of α-helices and β-sheets, indicating 
similar foldings for the three allergens. Despite of their secondary 
structural similarity, the uptake kinetics were markedly different, with 
Amb a 4 being more efficiently internalized by BMDCs, followed by 
Art v 1 and Par h 1. The defensin domain of Art v 1 was more stable 
to endolysosomal proteolysis compare to Amb a 4 and Par h 1, point-
ing to possible differences in their immunogenicity. All three allergens 
triggered IgE-mediated basophil degranulation ranging from 15 to 
40  %, demonstrating their allergenicity. The IgE reactivity of Art v 1 
was significantly higher in Austrian and Korean cohorts compared with 
Amb a 4 and Par h 1, while in the Canadian cohort all allergens showed 
similar reactivity. Additionally, in cross-reactivity studies, Amb a 4 and 
Par h 1 showed a higher cross-reactivity between them compared to 
Art v 1, which in some cases was unable to inhibit the response against 
Amb a 4 or Par h 1. This data suggests the presence of shared-common 
IgE epitopes while others are allergen-specific.
Conclusions: Art v 1, Amb a 4 and Par h 1 have similar structural fea-
tures but show different immunological behavior in vitro. The three 
allergens share common IgE epitopes while they display different IgE 
sensitization profiles in patients’cohorts.
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Background: Wheat is involved in 7.5  % of the severe food anaphy-
laxis according to the 2014 statistics of the French Allergo-vigilance 
Network. Exercise Induced Anaphylaxis is the most common form 
of wheat food allergy seen in adult patients and triggered by wheat 
intake and exercise in the following hours. Omega-5 gliadins (Tri a 19) 
have been documented for their interest in WDEIA diagnosis; how-
ever, in a number of cases, involvement of other proteins such as high 
MW and low MW glutenin subunits (HMW-GS and LMW-GS) and Lipid 
Transfer Protein (LTP) has been suggested.
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Wheat is a complex mixture of proteins; within a single cultivar, more 
than 100 constituents can be observed, among which, gliadins and 
glutenins present a high polymorphism and large sequence homolo-
gies. Two-dimensional immunoblot analysis after extraction of total 
proteins is a powerful technique to observe the diversity of IgE-bind-
ing in wheat flour, preserving the natural polymorphism, while elimi-
nating cross-contamination issues.
Materials and methods: Sera obtained from adult patients diagnosed 
with WDEIA were analyzed by immunoblot after two-dimensional 
separation of total proteins from the US wheat cultivar Butte 86. The 
availability of a proteomic map from this cultivar in which most of the 
major flour proteins were identified by tandem mass spectrometry 
makes it possible to determine the specific flour proteins that react 
with patients IgE. Comparison was carried out with ELISA results.
Results: As expected, most of the sera (70  %) reacted strongly to 
omega-5 gliadins in ELISA and detected multiple corresponding 2-DE 
spots. This reactivity was often accompanied in immunoblot by weak 
reactivity to certain LMW-GS and alpha-gliadins which may corre-
spond to cross-reactions, but that did not always correlate with ELISA 
results. The majority of patients with no IgE reactivity to omega-5 glia-
dins reacted to wheat LTP (about 20 % of cases). A few sera exhibited 
very different and diverse profiles: strong reactivity to all gliadins and 
LMW-GS, predominant binding to alpha-gliadins, specific binding to 
HMW-GS or specific binding to salt-soluble proteins including alpha-
amylase inhibitors and peroxidases.
Conclusions: These data suggest that multiple proteins may be 
involved in WDEIA, even though some of these reactions occur as 
cross-reactions to the major allergens omega-5 gliadins. Wheat lacking 
omega-5 gliadins would result in decreased allergenic potential but 
would not be suitable for individuals already diagnosed with WDEIA.
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Background: The prolamin superfamily comprises the largest num-
ber of allergenic plant proteins. The members possess a conserved 
skeleton of 8 cysteine residues that are connected by intramolecular 
disulfide bonds. The sulfur-rich prolamins of wheat, alpha-gliadins, 
gamma-gliadins and low molecular weight glutenin subunits dif-
fer by their organization into two structural domains: the C-terminal 
(Ct-) domain, which include the cysteine skeleton, and the N-terminal 
(Nt-) domain, which contains repeating motifs. Wheat gliadins are fre-
quently involved in food allergy to wheat and occasionally involved in 
baker’s asthma. The present study aimed to decipher the molecular 
basis of α- and γ-gliadin allergenicity.
Materials and methods: Different forms (natural/recombinant; 
native/reduced-alkylated) and fragments (Nt- and Ct-) of α- and 
γ-gliadins were produced to study the contribution of their structural 
domains and disulfide bonds to IgE binding. Their secondary structure 
was determined using synchrotron radiation circular dichroism (SRCD); 
sera from patients with food allergies to wheat or baker’s asthma were 
used to analyze IgE binding and triggering potential on RBL cells.
Results: The secondary structures of natural and recombinant proteins 
were slightly different. Compared with natural gliadins, recombinant 
proteins retained IgE binding but with reduced reactivity. When the 
proteins were reduced/alkylated, no significant effect was observed 
on the secondary structures of α- and γ-gliadin while significant 
decrease of IgE binding for both natural and recombinant gliadins was 
observed. Thus, reduction may have an indirect but drastic effect on 
the global folding of the proteins. Evaluation of the triggering poten-
tial of α-gliadin led to similar conclusions. IgE binding to peptides and 
recombinant domains of gliadins indicated the presence of epitopic 
regions in both domains.
Conclusions: In Conclusions, the α- and γ-gliadins in their native 
form should be preferentially used for IgE reactivity detection. As for 
other allergens of the prolamin superfamily, formation of disulfide 
bonds appears to be of importance for IgE binding to a and g-gliadins. 
Disulfide bonds in the Ct-domain most likely play a role in generating 
conformational epitopes within this domain or which are formed by a 
combination of residues from both domains.
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Background: Peanut allergy is one of the most severe food allergies 
worldwide. For estimating the allergenic risk of peanut allergens and 
for improving diagnostic tests, allergens that lead to severe clinical 
reactions need to be identified. There is evidence that lipophilic aller-
gens are associated with severe clinical symptoms, but many of them 
are not included in diagnostic test systems so far or are still unknown 
due to the complexity of the peanut matrix. Therefore, the aim of this 
study was to detect, isolate and characterize novel peanut allergens 
with lipophilic properties. Based on the observation that food process-
ing, for example roasting, influences the allergenicity of molecules, 
we also investigated the impact of roasting on the IgE-binding of the 
novel peanut allergens.
Materials and methods: Using lipophilic extraction methods and 
subsequent chromatographic separation techniques, we were able to 
isolate low molecular weight compounds in the range of 10–12  kDa 
under non-reducing conditions from roasted and unroasted peanuts 
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respectively. These proteins were further characterized by immuno-
blot analysis with sera of peanut-allergic patients. Allergic but non-
peanut allergic patients and non-allergic individuals were used as 
controls. Additionally, characterization of the allergenicity was per-
formed by basophil activation test and further functional properties of 
the molecules were analysed by antimicrobial activity assays.
Results: The low molecular weight compounds were identified as 
peanut defensins. The World Health Organization/International Union 
of Immunological Societies (WHO/IUIS) accepted them as two novel 
allergens (Ara  h  12, and Ara  h  13). Peanut allergic patients show a 
higher IgE reactivity against roasted peanut defensin compared to 
unroasted peanut defensin. Furthermore, we were able to show that 
defensins can activate basophils of peanut-allergic patients and have 
an inhibitory effect on mould strains, like Cladosporium and Alternaria, 
but not on the so far tested bacteria strains.
Conclusions: Our data suggests that the IgE reactivity correlates with 
severe clinical symptoms. For substantiating this observation and the 
impact of lipophilic allergens for component resolved diagnostics, 
future studies with higher numbers of peanut-allergic patients are 
needed.
Keywords: Peanut; Ara H 12/Ara H 13; Food allergy; Lipophilic extrac-
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Background: Although the uptake of the major peanut allergen 
Ara h 1 by dendritic cells (DCs) has been described, it is still not clear 
whether the allergen is able to sensitize by itself or whether there are 
other molecules involved. Evidence of the role of small molecules in 
the allergic sensitization, such as lipids, directly bound as ligands by 
the allergen or present in the allergen source, is emerging. Peanuts 
contain a significant amount of lipids. Therefore, we aimed to assess 
whether peanut lipids can bind to Ara h 1, and whether they can mod-
ulate the allergen-induced response in monocyte-derived dendritic 
cells (MoDCs).
Materials and methods: Ara h 1 was purified from commercially avail-
able roasted peanuts by standard chromatographic methods. Extrac-
tion of total lipids from peanut was performed using the chloroform/
methanol method. The lipid concentration was determined by the 
sulfo-phospho-vanillin method. Lipid binding to Ara h 1 was evaluated 
by 1-anilinonaphthalene-8-sulfonic acid (ANS) displacement assay. 
ANS was used at 5 µM, and peanut lipids were added to Ara h 1 at 5, 
50, and 100  µM. Fluorescence was measured at 484  nm. Monocytes 
were purified from PBMCs of 10 non-peanut allergic individuals and 
differentiated for 6  days with IL-4 and GM-CSF. The resulting MoDCs 
were treated with 10 µg/ml peanut lipids alone or in combination with 
10  µg/ml Ara h 1. TNF-α levels in the cell culture supernatant were 
measured by ELISA.
Results: Ara h 1 incubated with peanut lipids at the highest concen-
tration, showed a reduction of ANS fluorescence by 30  % compared 
with Ara h 1 incubated with ANS alone. In MoDCs from 5 of 10 non-
peanut allergic individuals Ara h 1 increased the TNF-α production. 
Interestingly, peanut lipids reduced TNF-a levels in response to Ara h 
1 stimulation by 65 %. In the other 5 donors, Ara h 1 did not elicit any 
TNF-α response, but peanut lipids in combination with Ara h 1 showed 
a non-significant increase of TNF-α levels.
Conclusions: We observed that lipids extracted from peanut were 
able to bind to Ara h 1. Furthermore, peanut lipids diminish the Ara h 
1-induced TNF-α response in MoDCs of non-allergic individuals. These 
data indicate that peanut lipids do play a role in the modulation of the 
immune response to Ara h 1.
Supported by the Austrian Science Fund Doctoral Program MCCA W 
1248-B13.
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Background: Several studies reported data, sometimes contradictory, 
about the effect of heat-treatment of egg on allergy using mice or sera 
form egg allergic patients; but the possible impact of aggregation was 
not considered. Aggregation is an irreversible modification of pro-
teins by formation of new intermolecular bonds. Aggregates of vari-
ous morphologies may be generated depending on physico-chemical 
conditions. Ovalbumin, a major allergen of egg white, is prone to 
aggregate upon thermal processing. This study compares allergenicity 
of native and aggregated ovalbumin as large agglomerated particles 
on parameters from both phases of allergic reaction: sensitization and 
elicitation.
Materials and methods: An ovalbumin solution (pH5–0.8  M) was 
extensively heated (80  °C for 6  h) to generate large agglomerated 
aggregates. A murine model of allergy was used to evaluate influence 
of ovalbumin structure on Ig production upon sensitization by intra-
peritoneal route. Using sera from mice sensitized to native or aggre-
gated ovalbumin, Ig-binding and degranulation capacities of native 
and aggregated ovalbumin were measured by ELISA and with RBL 
cells.
Results: We showed that heat-aggregation of ovalbumin as large par-
ticles enhanced IgG production and promoted a shift toward IgG2a 
production in mice (pro-Th1 profile) compared to native ovalbumin 
(pro-Th2 profile). Moreover, the IgG repertory differed i.e. aggregated 
ovalbumin generated antibodies able to bind both native and aggre-
gated ovalbumin. Large agglomerated aggregates displayed lower 
IgE-binding and RBL activation capacities.
Conclusions: This work illustrates links between structure of ovalbu-
min and allergenicity potential on parameters from both sensitization 
and elicitation phases of the allergic reaction. It would appear that 
large agglomerated aggregates of OVA increased sensitization by pro-
ducing more IgG and decreased elicitation.
Keywords: Egg allergy; Food processing; Aggregation; Basophil 
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Background: Allergic reactions against certain foods are triggered 
by epitopic regions in the allergen’s amino acid sequence that show 
the ability to bind IgE. For an allergic reaction to occur, the passage of 
these epitopes through the intestinal mucosa in an immunologically 
intact form is required (not considering oral allergies that tend to show 
far less severe symptoms). Epitopes have been identified for many 
major tree nut allergens known to be able to trigger anaphylaxis. Still 
very little is known about their molecular fate during the gastro-intes-
tinal passage and the IgE-binding potential of the digestive products.
Materials and methods: A standardised multistage in-vitro model 
(Minekus et  al. 2014), simulating the three phases of human diges-
tion (oral, gastral, intestinal), was applied to ground hazelnut kernels. 
The time-dependent course of the in-vitro digestion processes was 
analysed by SDS-PAGE. A software assisted HPLC-MS/MS proteomics 
approach on a high resolution orbitrap mass spectrometer was used 
to elucidate the structure of peptidic degradation products and assess 
their relative concentrations over time.
Results: Degradation was observed for both major allergens from 
hazelnut kernels, Cor a 9 and Cor a 11, in the gastral and intestinal 
phases accompanied by the formation of low-molecular products. 
While Cor a 11 showed higher stability against digestion both mole-
cules were largely degraded after 120 min in the gastral and 10 min in 
the intestinal phase. The molecular structures of several peptidic prod-
ucts were identified by mass spectrometry. Time dependent formation 
and degradation kinetics of these peptides indicate that the gastroin-
testinal digestion of the intact allergens follows a multi-stage mecha-
nism based on consecutive enzymatic activity resulting in a broad 
variety of peptidic structures. While the concentration of the intact 
allergens decreased rapidly during the digestion processes, several of 
the peptidic degradation products overlap with previously identified 
linear epitopes.
Conclusions: Human digestion significantly affects the molecular 
structure of allergens by gastral and intestinal degradation processes. 
The major hazelnut allergens Cor a 9 and Cor a 11 are shown to be 
largely degraded before they reach the intestinal lumina whereas par-
ticular parts of the protein sequence resist digestion. The stability of 
specific linear epitope against gastrointestinal degradation therefore 
appears to play a crucial role for their allergenic potential.
Keywords: Hazelnut allergy; In-vitro digestion; High resolution mass 
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Background: Rice allergy is a problem in both, Asian and Western 
countries. Several rice proteins have already been identified as causa-
tive agents of rice allergy. Since the first case of occupational contact 
urticaria was reported in a housewife and was due to the handling of 
rice bran in the form of rice bran pickles, it is necessary to understand 
the allergenicity of whole brown rice, not only polished rice but also 
rice bran, and to consider the sensitization by percutaneous exposure. 
In this study, we analysed the distribution of rice allergens in brown 
rice grain and the allergenicity in health food and cosmetics contain-
ing rice bran.
Materials and methods: Brown rice (Oryza sativa L. cv koshihikari), 
polished rice, and rice bran were powdered and suspended in 1  M 
NaCl containing protease inhibitors or Laemmli sample buffer and pro-
teins were extracted. For the health foods and cosmetics containing 
rice bran, samples were suspended in phosphate-buffered saline (PBS) 
and proteins were extracted. The extracted protein solutions were 
then centrifuged and filtered. The proteins were separated by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS–PAGE) under 
reducing conditions, and analysed using western blotting with rabbit 
polyclonal antibody specific to two rice allergens, 19 kDa globulin and 
52 kDa globulin.
Results: The results of western blot analysis revealed that the 19 kDa 
globulin was hardly detected in the rice bran but was detected in the 
brown rice and the polished rice. On the other hand, 52  kDa globu-
lin was detected in the rice bran and the brown rice, and was hardly 
detected in the polished rice. Regarding the proteins from the health 
foods and cosmetics, some of them showed clear protein bands and 
the others hardly showed the bands. Furthermore, 19 and/or 52 kDa 
globulins were detected in some products because the western blot 
analysis used the rice allergen specific antibody.
Conclusions: 19 and 52 kDa globulins are localized mainly in the inner 
and outer parts of the rice grains, respectively. The finding that some 
health foods and cosmetics with rice bran contain 19 and 52 kDa glob-
ulins indicates that the patients with rice allergy need to be careful 
about using these products.
Keywords: Rice; Rice bran; Globulin; Health foods; Cosmetics
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Background: Peanut allergy is one of the most dangerous food aller-
gies. Ara h 2 is a major peanut allergen. At present, peanut allergen-
specific immunotherapy is not available for clinical use. We aimed to 
produce a hypoallergenic mt (mutant) Ara h 2.
Materials and methods: An in silico designed mtAra h 2 in which IgE-
binding surface exposed loops were removed and wt (wild-type) Ara h 
2 with a hexahistidyl-tag were expressed in Trichoplusia ni BTI-TN5B1-4 
‘‘HighFive’’ cells. Following purification from the supernatants, mtAra 
h 2 and wtAra  h  2 protein expression was verified by SDS-PAGE and 
Western blotting. Physicochemical characteristics were determined by 
mass spectrometry, CD spectrometry and N-terminal sequencing. IgE-
binding to purified n (natural) Ara h 2, wtAra h 2 and mtAra h 2 was 
tested by direct ELISA, Western blotting and inhibition ELISA.
Results: Mass spectrometry analysis confirmed the absence of post-
translational modifications for the main fraction of wtAra h 2. The 
folding and the N-terminal amino acid sequence of wtAra h 2 cor-
responded to the natural protein. For mtAra h 2, mass spectrometry 
analysis revealed a mass corresponding to the predicted size. The fold-
ing as well as the N-terminal amino acid sequence were identical to 
the natural protein with removed IgE-binding loops. Immunoblots 
of Ara h 2-sensitized patients showed lower IgE-binding to mtAra h 
2 than to the wild-type and the natural protein. In direct ELISA, five 
peanut allergic patients’ sera revealed a 20–50 % reduced IgE-binding 
to mtAra h 2 compared to wtAra h 2. Inhibition ELISAs showed signifi-
cantly reduced IgE-binding of mtAra h 2 compared with nAra h 2.
Page 21 of 34Clin Transl Allergy 2016, 6(Suppl 2):38
Conclusions: The obtained results indicate that mtAra h 2 is a prom-
ising template for designing the next generation of hypoallergenic 
mutants.
Supported by the Austrian Science Fund doctoral program W1248-B13 
(Doctoral Program Molecular, Cellular and Clinical Allergology, MCCA).
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Background: Immunotherapy, the only causative treatment for type 
I allergies, may cause severe side effects. Therefore new strategies for 
safer forms of specific immunotherapy are needed. One strategy is to 
modify allergens in a way that they show reduced IgE-binding capac-
ity and thus upon application have a lower risk of inducing severe side 
effects.
Materials and methods: We previously produced a hypoallergenic 
mutant of the major fish allergen, parvalbumin, by introduction of 
point mutations into the two calcium-binding sites. To see whether 
the same strategy can also be applied for other calcium-binding aller-
gens, we introduced by site-directed mutagenesis the same muta-
tions into the calcium-binding sites of Phl p 7, a polcalcin from timothy 
grass. The histidine-tagged wildtype and mutant variant of Phl p 7 
were expressed in Escherichia coli and purified using affinity column 
chromatography.
Results: The successful expression of the wildtype and mutant pro-
teins was shown in immunoblots using anti-histidine as well as anti-
Phl p 7 antibodies. Immunoblots and dot blots with sera from grass 
pollen allergic individuals showed a strongly reduced IgE-binding 
capacity of the mutant as compared to the wildtype allergen. These 
results demonstrated that mutagenesis of specific amino acids 
involved in calcium-binding generated a hypoallergenic Phl p 7 mol-
ecule. Circular dichroism spectroscopy experiments performed in 
the presence and absence of calcium further showed that the Phl p 7 
mutant had lost the calcium-binding capacity. To analyze whether the 
Phl p 7 mutant variant represents an immunogenic molecule, rabbits 
were immunized with the protein. ELISA analyses showed that the 
Phl p 7 mutant induced specific IgG antibodies, which recognized the 
mutant protein and also the Phl p 7 wildtype allergen.
Conclusions: By mutagenesis of specific amino acids involved in cal-
cium-binding we thus generated a hypoallergenic Phl p 7 molecule 
which still has the potential to stimulate the immune system. We 
therefore suggest, that Phl p 7 mutant protein could be used for spe-
cific immunotherapy of patients sensitized to calcium-binding pollen 
allergens.
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Background: Pollen from Fagales trees, especially birch pollen, is 
the main cause of early seasonal allergy in the temperate climate 
zone of the Northern hemisphere. Birch pollen allergic patients fre-
quently develop allergies also towards various fruits, vegetables and 
nuts belonging to the botanical families of Rosaceae, Apiaceae and 
Fabaceae, respectively. Common symptoms in birch allergic patients 
include the oral allergy syndrome against apple and hazelnut. Allergen 
immunotherapy (AIT) is currently the only strategy to effectively cure 
allergies and the success of the treatment is influenced by the devel-
opment of specific blocking antibodies. The aim of this study was to 
investigate whether blocking antibodies induced by successful birch 
pollen AIT using conventional allergen extracts would inhibit IgE bind-
ing to Bet v 1 related pollen as well as food allergens.
Materials and methods: Therefore, a panel of 8 Fagales pollen aller-
gens (Aln g 1.0101 from alder, Bet v 1.0101 from birch, Car b 1.0109 
from hornbeam, Cas s 1.0101 from chestnut, Cor a 1.0104 from hazel-
nut, Fag s 1.0101 from beech, Ost c 1.0101 from hop-hornbeam and 
Que a 1.0301 from oak) as well as two related food allergens (Mal d 
1.0108 from apple and Cor a 1.0401 from hazelnut) were recom-
binantly produced in E. coli, purified to homogeneity and analyzed 
physico-chemically. Serum samples from 5 different birch pollen aller-
gic patients were collected before, after reaching maintenance dose 
and after 1-year after initiation of AIT with birch pollen extracts. Treat-
ment efficacy was analyzed by nasal provocation tests. Facilitated anti-
gen binding (FAB) assays were performed to determine the blocking 
activity of AIT induced IgG.
Results: All five patients included in the study showed an improve-
ment of nasal provocation scores during AIT. Moreover, all patients 
developed Bet v 1 specific blocking antibodies. However, FAB assays 
revealed that not all donors developed blocking antibodies against 
the whole panel of Bet v 1 related allergens.
Conclusions: Therefore, we believe that successful birch pollen AIT 
cannot always ameliorate allergic symptoms towards related allergens 
emphasizing the need for improved treatment strategies.
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Background: Allergy to pets is a public health problem [1–3]. Geneva 
is a multiple complex community [4] where the use of component 
resolved diagnostic (CRD) is unavoidable [5].
Materials and methods: Multiplex microarray Isac® 112 was per-
formed for 431 patients from 2012 to 2014; prevalence of pets aller-
gens were recorded. Results of subcutaneous immunotherapy started 
between 2005 and 2010 on 58 patients allergic to pets were analysed.
Results: Prevalence of Feld1 is 42  % (181/431). In 54  % of the cases, 
sensitization to Feld1 is associated with another pets allergen sensiti-
zation as lipocalin and serum albumin: Canf5 in 55 % (53/97), Canf1 in 
44 % (43/97) and Feld4 in 42 % (41/97) for the most frequent ones. On 
the 58 patients taken in charge by subcutaneous immunotherapy (SIT) 
started between 2005 and 2010 for pets allergy, 100  % (58/58) were 
complaining for cat allergy, 19 % (11/58) were complaining for symp-
toms for other pets than cat, 55 % (32/58) have asthma associated to 
rhinitis and 43 % (25/58) have a food complain allergy associated. 97 % 
of patients are polyallergic with a clinical allergy other than pets. SIT 
clinical improvement score for pets was 68  % for SIT started in 2005 
(end in 2009–2010) compared to 91 % for SIT started in 2010 (end of 
SIT 2014–2015). Adverse systemic reaction (ASR) were recorded for 7 
patients (2 grade II and 5 grade III) without grade IV. All grade III were 
asthmatic patients.
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Conclusions: Pets habits as food habits have changed in most urban 
European areas: they share frequently human life and are indoor aller-
gens. It is shown here that in a multicomplex community like Geneva, 
most of patients consulting an allergy setting are highly sensitized to 
Feld1 and have another pets minor allergen’s sensitization associated 
to Feld1. Once allergic to pets, >90 % of the patients are co-allergic to 
pollens and food. Immunotherapy being the only treatment to cure 
the allergic disease [6, 7], improving schedule for individual patient 
should be an option. Component resolved diagnostic routine used in 
this setting is able to improve the SIT efficacy from 68 to 91 %, with an 
average (median) score of improvement for pets allergy by SIT of 84 %. 
ASR were recorded for 12 % of patients.
SIT for pets is highly efficient and secure despite polysensitization and 
polyallergy. As for Canf1 for dog allergy [8], Feld1 alone seems not suf-
ficient for diagnosis and consecutively treating cat allergic patient.
Keywords: Component resolved treatment; Subcutaneous immuno-
therapy; Pets allergy; Polysensitization; Molecular allergology
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Background: Neutrophils are present in large numbers in allergic late-
phase reactions. However, it is not yet clear whether they contribute 
to allergic inflammation. These professional phagocytes might present 
the allergen to allergen-specific T cells since they express MHC class II 
molecules upon stimulation with certain cytokines, chemokines and 
bacterial factors, such as GM-CSF, TNF-a, IL-8, IFN-g and LPS, respec-
tively. In fact, murine neutrophils have been shown to process and 
present antigens to CD4+ T-cells.
Our aim is to assess whether human neutrophils act as antigen-pre-
senting cells for allergen-specific T-cells.
Materials and methods: Neutrophils isolated from the peripheral 
blood of allergic donors were cultured under different conditions and 
analyzed for the expression of MHC class II, CD40, CD80, and CD86, 
by flow cytometry. Surface binding, internalization and intracellu-
lar degradation of fluorescence-labelled Bet v 1 by neutrophils were 
compared with monocytes. Microsomal proteases were isolated from 
both cell types and incubated with Bet v 1. The resulting proteolytic 
fragments were sequenced using mass spectrometry. Finally, neu-
trophils and monocytes were cocultured with Bet v 1-specific T-cell 
cultures generated from birch-pollen allergic donors in the pres-
ence or absence of Bet v 1 and proliferative responses of T-cells were 
assessed.
Results: A cocktail of IL-3, GM-CSF and IFN-g enhanced the expres-
sion of HLA class II and CD80 on neutrophils. Neutrophils effectively 
internalized Bet v 1 and their uptake and endolysosomal degradation 
of the allergen was faster than by monocytes. In addition, neutrophils 
processed longer peptides of Bet v 1 than monocytes. Neutrophils 
pulsed with Bet v 1 induced proliferation in Bet v 1- specific T- cells 
specific for different epitopes distributed over its entire amino acid 
sequence. However, monocytes were the more potent antigen-pre-
senting cells.
Conclusions: Our data provide evidence that neutrophils may serve as 
antigen-presenting cells for allergen specific T-cells and thereby, play a 
role in the late phase reaction of IgE-mediated allergy.
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Background: Allergy is an IgE-mediated hypersensitivity reaction 
against harmless antigens. Like any immune response, allergic reac-
tions are mediated by both innate and adaptive immunity. T cells are 
part of adaptive immunity and play a main role in the maintenance of 
IgE-mediated allergy. The function of CD4+ T cells in the pathophysiol-
ogy of allergic disorders has been extensively investigated while the 
role of CD8+ T cells is still poorly understood and controversial. The 
aim of this project is to characterize allergen-specific CD8+ T cells in 
patients with different allergic manifestations (rhinoconjunctivitis, 
atopic dermatitis and atopic bronchial asthma).
Materials and methods: Different seasonal (birch pollen and grass 
pollen) and perennial allergens (cat dander and house dust mite) 
were included. PBMCs from allergic patients were stained with the 
proliferation dye efluor 670 and incubated with allergen. Proliferat-
ing CD3+CD8+ cells were then assessed for the expression of differen-
tiation markers (CD27, CD28, CD45RO, CXCR3, CRTh2, PD-1), homing 
factors (CCR4, CD62L, CD29b), intracellular cytokines (IL-4, IL-5, IL-13, 
IL-17, IL-22 and IFN-γ, TNF-α), and cytotoxic proteins (granzyme B and 
perforin) by flow cytometry and compared to non-proliferating CD8+ 
T cells.
Results: We found significant numbers of proliferating CD8+ T cells in 
all allergic manifestations, however, largest numbers were detected 
upon stimulation with house dust mite & grass pollen extracts. Fur-
thermore, we observed a higher production of IL-4, granzyme B and 
perforin in proliferating than non-proliferating CD8+ T cells. In addi-
tion, a significantly higher expression of CD27, CD45RO, CD62L, and 
CD29b was detected in allergen-reactive CD8+ T cells.
Conclusions: So far, we could confirm the existence of allergen-reac-
tive IL-4+ CD8+ T cells in different allergic manifestations. These cells 
produce cytotoxic proteins and will be further characterized in future 
experiments.
Poster Session 5: Molecular and cellular diagnostic tests
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Background: In a world where information is instantly available, the 
need to provide rapid, near-patient, quantitative diagnosis is becom-
ing an essential requirement. In response to this demand we have 
developed biosensors with a nanometric-size reaction chamber that 
enhances molecular interactions and thereby reduces incubation 
times of immunoassay from hours to seconds. The first application 
available for this system quantifies total circulating IgE from as lit-
tle as 50  ul of blood in 5  min. The patient’s sample is diluted with a 
solution containing fluorescently-labelled detection biomolecules 
that specifically bind to IgE, thus forming fluorescent molecular com-
plexes. Through capillarity, the solution enters the biosensor where 
complexed IgE are captured on the targeted area. Fluorescence is then 
measured by a miniaturized microscope in the abioSCOPE reading 
unit, a novel and versatile in vitro diagnostic platform.
Materials and methods: Matrix commutability, test linearity, effect of 
potential interfering substances and a comparison study have been 
performed to determine key analytical performance characteristics of 
the test.
Results: The test is compatible with capillary blood or with serum or 
plasma samples. It has an assay measurable range from 10 to 400 kU/l 
of IgE. High levels of nonIgE immunoglobulins, icteric, hemolytic or 
lipemic samples do not interfere with test results. A comparison study 
between total IgE tested in the abioSCOPE against an industry gold 
standard (ImmunoCAP Total IgE® in Phadia 250) showed an excellent 
agreement between the two systems, with values of sensitivity, speci-
ficity and accuracy of 88.7, 87.5 and 88.2 %, respectively.
Conclusions: Thanks to this miniaturized biosensor and the abio-
SCOPE, non-invasive quantification of protein at the point-of-care is 
performed in 5 minutes from a drop of whole blood collected from 
the patient’s fingertip, whereas time-to-results using laboratory-based 
instruments usually takes hours. Validation of this technology allows 
the development of allergen-specific IgE tests to aid allergists in mak-
ing precise and comprehensive allergy diagnoses.
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Background: More than 25 % of the population suffer from IgE-medi-
ated allergic reactions and the number of allergic people is increasing. 
Consequently, there is increasing demand for strategies targeting early 
diagnosis, prevention and treatment of allergic sensitisation. Allergy 
diagnosis is traditionally carried out using allergen extracts in provoca-
tive or serological tests. By using component-resolved diagnostics, 
however, it is possible to identify the specific disease-eliciting allergen 
and, thus, to introduce more personalised and effective immunother-
apy treatments for sensitised individuals.
Materials and methods: A simple and rapid Array-in-Well (AiW) plat-
form provides simultaneous IgE reactivity profiling for multiple aller-
gens using only minute amounts of serum.
Results: To establish a proof-of-concept, we printed purified and MS 
validated recombinant or native allergens representing relevant res-
piratory allergen sources, such as dog, horse and birch pollen aller-
gens as an array into wells of 96-well microtiter plate. The IgE profiling 
against these allergens was carried out using serum samples collected 
from allergic donors. The binding of IgEs present in serum samples to 
the total of nine allergens present in a single well was measured and 
subsequently detected by fluorescently labelled human IgE-specific 
secondary antibodies. Fluorescence imaging of the microarrays was 
used to quantify the fluorescence intensity in each spot, thus resulting 
in a quantitative profile of IgEs present in the sample.
The allergenic activity of recombinant allergens in solution was meas-
ured by a competitive immunoassay on the above established AiW 
platform. Two recombinant allergens, wild-type allergen vs. natural 
hypoallergen, with different allergenic properties were compared by a 
competitive assay. The binding of serum IgEs to immobilised allergens 
was inhibited by the increasing amounts of the soluble allergens.
Conclusions: The developed allergen microarray provides a prom-
ising, simple and cost-effective tool for simultaneous analysis of 
allergy-associated IgE antibodies enabling also the biological activity 
measurement of the allergens by the competitive immunoassay. The 
assay has apparent potential for high-throughput IgE profiling in the 
large patient cohorts targeting wide variety of allergens as well as the 
analysis of the allergenic activity of allergens.
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Background: In tropic and sub-tropic regions American cockroach 
(Periplaneta americana) is a major source of indoor allergens, fre-
quently causing allergic reactions and asthma. From this source no 
single major allergen is able to predict patients’ sensitization and 
therefore serve as a marker allergen in allergy diagnosis. As a result 
there is a need for component resolved diagnosis (CRD) in American 
cockroach allergy to determine sensitization patterns and point out 
treatment strategies. Within the ERA-Net New Indigo project GENALL 
(Genetically engineered allergens for component-resolved diagnosis 
and immunotherapy of airway allergies) a set of well-characterized 
recombinant Periplaneta americana allergens will be produced.
Materials and methods: Per a 1.0103 (residues 197–378), Per a 2.0101, 
and the C-terminal domain of Per a 3.0101 (residues 426–675), were 
recombinantly produced in E. coli and purified to homogeneity. Pro-
teins were physico-chemically characterized by mass spectrometry 
(MS), amino acid analysis (AAA) and circular dichroism spectroscopy 
(CD). The IgE binding capacity of the proteins was determined by 
ELISA experiments using sera of cockroach allergic patients from India 
(n = 25) and South Korea (n = 10).
Results: In MS the primary sequence of the proteins was confirmed. 
With AAA the expected amino acid distribution was obtained and the 
exact protein concentrations were determined. Spectra obtained from 
CD revealed partially intact secondary structural elements. The ability 
of the three allergens to bind IgE was confirmed by ELISA. While for 
Per a 2 and Per a 3 sensitization frequencies ranged from 40 to 60 %, 
Per a 1 appeared to be a minor allergen in the tested patients’ cohorts, 
showing reactivity with only one of the tested sera.
Conclusions: Recombinantly produced Per a 1, Per a 2 and Per a 3 
were physico-chemically characterized, and their IgE binding capacity 
was shown by ELISA. In further studies, all ten described Periplaneta 
americana allergens will be used for testing large patients’ cohorts 
from Europe, Asia and America in order to evaluate the sensitization 
patterns. Cross-reactivity studies between American cockroach aller-
gens and their homologues from German cockroach (Blattella german-
ica) might help to elucidate the primary sensitizer.
The work was funded by the ERA-Net New INDIGO project I 1152 
(GENALL) of the Austrian Science Fund (FWF).
Keywords: Cockroach allergy; Component resolved diagnosis
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Background: In most cases, the diagnostic tests with conventional 
extracts are often positive for Bee (B), Wasp (W) and Polistes (P) venom, 
which may be due to double sensitization or cross-reactivity, stickling 
the decision of specific immunotherapy (SIT).
Materials and methods: Characterization of sensitization profile 
through the use of recombinant allergens for diagnosis of hymenop-
tera venom allergy, identifying dual sensitization or cross-reactivity. 
Contribution of basophil activation test (BAT) in patients (pts) with sys-
temic reactions and both negative skin test (ST) and specific IgE (sIgE). 
112 pts (74 men, 38 women, 21–78 years) with systemic reactions to 
Hymenoptera stings, not submitted to SIT, and 20 atopic controls with-
out history of reaction to insect stings. ST were performed with com-
mercial extracts (CE) of Bee (B), Wasp (W) and Polistes (P) venom, sIgE 
to the same extracts and recombinant allergens: Api m1, Ves v1, Ves v5 
and Pol d5 and CCDs (ImmunoCapÒ). In BAT both venoms were tested 
in six concentrations: 0.01; 0.02; 0.04; 1.0; 2.5 and 5  ug/ml (Flow2 
CAST®).
Results: Based on sIgE, 50pts (45  %) were polisensitized to B, W, P 
and 55 pts (49  %) were monosensitized: 30 (B), 20 (W), 5 (P). In 7 
pts (6 %) ST and sIgE were both negative. Of the 55 polisensibilized 
pts, 23 (42 %) had double sensitization (positive sIgE to Api m1 and 
Ves v1); the remaining 32 (58 %) revealed cross-reactivity (15 Api m1 
and 16 Ves v1/Vesv5 and 1 Pol d5). The monosensitized pts to W/P 
had positive sIgE to Ves v1 and/or Ves v5 and Pol d5. 25 (83  %) of 
the sensitized pts to B had positive Api m1. The sIgE to CCDs was 
positive in 15 pts, all with double sensitization with CE, indicating 
cross-reactivity between species. The 7 pts with negative sIgE had 
negative recombinants. The specificity for the four components was 
high, since monosensitized pts showed no positive sIgE for other 
species, and only a positive control had a positive sIgE to Ves v1/
Ves v5. The BAT was performed in 5 pts (with negative ST and sIgE) 
and it was positive in 3, at concentrations of 0.04 and 2.5 ug/ml for 
B venom.
Conclusions: The determination of sIgE to Api m1, Ves v1/Ves v5 and 
Pol d5 is a useful diagnostic method allowing discrimination between 
dual primary sensitization and cross-reactivity, as well as a better 
selection of patients for SIT. The BAT may be useful in cases of difficult 
diagnosis.
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Background: The ISACâ microarray explores sensitization to 112 
molecular allergens. The analysis of such a broad panel is useful for the 
detection of overlooked associations. We report cosensitization to Alt 
a 1 (Alternaria alternata acidic glycoprotein) and Act d 2 (kiwi thauma-
tin-like protein TLP), the only TLP tested by ISACâ.
Objectives: - to study the frequency of Alt a 1 and Act d 2 
cosensitization.
 - to try and understand its mechanism
Materials and methods: Data from 807 ISACâ 112 microarrays 
(Thermo Fisher) were collected:
221 patients from Lyon, Central France (62  % males, mean age: 
12 years)
586 patients from Marseille, Southern France (51 % males, mean age: 
13 years)
Results: In both centers, more than 80 % of patients sensitized to Act 
d 2 were also sensitized to Alt a 1 (Lyon 82  %, Marseille 86  %). Con-
versely, only 35  % of Alt a 1 sensitized patients from Lyon were also 
sensitized to Act d 2, but the percentage reached 61  % in Marseille 
patients. The median level of Alt a 1 specific IgE (sIgE) was significantly 
higher in cosensitized patients than in Alt a 1 monosensitized patients: 
5.4 ISU versus 1.99 for Lyon (p < 0.01) and 17.3 ISU versus 3.7 for Mar-
seille (p < 0.0001).
Importantly, cosensitization to Alt a 1 and other kiwi allergens present 
on the microarray (Act d 1, Act d 5, Act d 8) was infrequent.
Clinical data were not available for all patients. Act d 2 sensitiza-
tion was not always clinically relevant with respect to kiwi fruit. Most 
patients cosensitized to Alt a 1 and Act d 2 displayed respiratory 
symptoms.
Discussion: Gomez-Casado C. (FEBS Letters 2014) demonstrated that:
  • Alt a 1 is co-localized with Act d 2 in kiwi
  • electrostatic interactions exist between Act d 2 and Alt a 1
 • Alt a 1 behaves as a competitive inhibitor of the TLP.
Moreover, Act d 2 spotted on ISACâ is a natural purified allergen (as 
opposed to Alt a 1 which is a recombinant one). Therefore, Act d 2 
might be contaminated by Alt a 1 during the purification process 
which could induce recognition of Act d 2 spots by Alt a 1 sIgE. Alter-
natively, true cross-reactivity between Act d 2 and Alt a 1 cannot be 
excluded at this stage.
Conclusions: Considering its frequency, Alt a1/Act d 2 cosensitiza-
tion observed in 2 centers is unlikely to be incidental. The mechanism 
underlying this finding needs further investigation, including the 
search for (i) Alt a 1 association with other TLP, (ii) structurally similar 
epitopes, and (iii) clinical relevance of Act d 2 sensitization.
Keywords: Act D 2; Alt A 1; Kiwi; Alternaria; Thaumatin-like-protein
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Background: Molecular allergy diagnostics is currently a well-estab-
lished, valuable tool for classifying peanut-related reactions in either 
genuine peanut allergy or cross-reactions. This is an important point, 
given the difference in further severity evaluation, prognostic predic-
tion, and therapeutic management of the true peanut allergic patient.
Materials and methods: We took advantage of the singleplex ALFA 
method (DrFooke) in order to study the performances of most impor-
tant peanut allergens (Ara h 6, Ara h 2, Ara h 1, Ara h 9) in peanut 
allergic or peanut tolerant patients. Serum specific IgE (sIgE) to cross-
reactive carbohydrate determinants (CCD) and raw peanut extract 
were also assessed. ALFA results for sIgE (colorimetric result units) 
were compared to ImmunoCAP 250 (expressed in kUA/L) and Immu-
noCAP ISAC (expressed in ISU) sIgE data for the same serum sam-
ples from 19 peanut-allergic patients (9 boys) with a median age of 
10 years (2–19). For semiquantitative comparison, we defined 7 classes 
for each method, based on the intensity of the sIgE signal.
Results: Concordance between two methods was considered as 
ideal if the results fit in the same class, good if the difference was ±1 
class, and poor for ±2 classes. Results were considered as discordant 
when the difference was ≥2 classes (Table  4). No positive/negative 
discordance was seen for Ara h 2 and Ara h 6. Ideal or good concord-
ance for these two allergens ranged from 74 to 89 %. On the contrary, 
despite 50–68 % ideal or good concordance for Ara h 1 and Ara h 9, 
positive/negative discordance was frequent for these allergens, with 
ALFA method yielding more positive results than both ISAC and 
ImmunoCAP.
Conclusions: Molecular allergy diagnostics for peanut allergy with 
the ALFA method performs well in comparison with other methods. In 
particular, Ara h 2 and Ara h 6, peanut major allergens in both tem-
perate and mediterranean environments, display a very good correla-
tion with both ImmunoCAP ISAC and singleplex ImmunoCAP. No false 
positive or false negative result was reported for these two allergens 
in our patient group. In conclusion, the Dr. Fooke ALFA kit is a reliable 
tool for peanut molecular allergy diagnostics.
Keywords: Peanut allergy; Ara H 1; Ara H 2; Ara H 6; Ara H 9
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Background: The aim of this study was to ascertain if negative specific 
IgE to peanut component Ara-h2 is able to predict peanut tolerance 
whilst positive specific IgE to Peanut Ara-h2 is more likely associated 
with peanut allergy in a population of cosmopolitan children with 
suspected peanut allergy, resident in the central and Greater London 
region and attending a tertiary level allergy clinic.
Materials and methods: The study is a retrospective evaluation of 
peanut challenge cases in relation to peanut challenge outcomes, 
results of peanut skin prick test and peanut specific IgE and specific 
IgE for peanut molecular components (Ara-h2 and Ara-h8). In addition 
children with a recent (within 12  months) history of peanut reaction 
for whom specific IgE for peanut molecular component was available 
were also included in the analysis.
Results: The analysis of our data suggests that specific IgE to Ara h 2 
is a more specific test for predicting outcome of a peanut food chal-
lenge when compared to peanut specific IgE, with specificities rang-
ing from 85 to 95 %, depending on the cohort examined. These similar 
values across cohorts are reflected in this study data. In our peanut 
allergic subjects the median value for Ara h2 was 6.7 and 0.09 kua/l in 
the peanut tolerant group. This was found to be statistically significant 
Table 4 Comparison of peanut allergen sIgE measured with three methods: ALFA, ImmunoCAP®, ISAC®
Methods Allergens Concordance (%) Positive/negative discordance
Ideal Good Poor None
ALFA® and singleplex  
ImmunoCAP®
Ara h 2 26 63 11 0 0
Ara h 1 41 24 12 24 9, with 4 ALFA positive, ImmunoCAP negative, 
and 1 ALFA negative, ImmunoCAP positive
Ara h 9 22 44 28 6 7, with 5 ALFA positive, ImmunoCAP negative, 
and 2 ALFA negative, ImmunoCAP positive
CCD 53 33 13 0 4, all ALFA positive, ImmunoCAP negative
Peanut extract 17 41 41 6 0
ALFA® and ISAC®  
microarray
Ara h 2 42 32 16 11 0
Ara h 6 16 58 11 16 0
Ara h 1 17 33 28 22 9, all ALFA positive, ISAC negative (4 Immuno‑
CAP positive, 4 ImmunoCAP negative, 1 not 
assayed with ImmunoCAP)
Ara h 9 44 17 28 11 9, all ALFA positive, ISAC negative (4 Immuno‑
CAP positive, 5 ImmunoCAP negative)
CCD 33 39 22 6 10, all ALFA positive, ISAC negative (4 Immu‑
noCAP positive, 4 ImmunoCAP negative, 2 
not assayed with ImmunoCAP)
For each method, sIgE results were converted in 7 classes (0 to 6) based on the intensity of the measured signal. Ideal concordance was defined as two same-class 
results, good concordance as adjacent class results, poor concordance as a difference of 2 classes, and no concordance when results differed by more than 2 classes
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(p = <0.0001). The AUC for was found to be 0.91 and therefore signifi-
cant in predicating peanut challenge outcome.
Conclusions: Different cut off points for SPT and specific IgE have been 
presented in a number of studies, but so far either a low sensitivity or 
low specificity has reduced the reliability as a replacement for oral 
challenges and thereby the clinical impact. The usage of component-
resolved diagnostics have been reported as more useful compared to 
whole peanut protein specific IgE. In line with other studies we found 
that Ara h 2 was the best predictor of peanut challenge outcomes. 
Whilst the results of the study do not reduce the need for challenging 
patients, the need for food challenges may be reduced by combing the 
results of Ara H2 IgE and clinical history.
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Background: Component resolved diagnosis (CRD) provides a step 
forward in identifying trigger allergens and assessing the risk of severe 
reactions in food allergy. This study aims to characterize, over a one-
year period, the clinical and molecular profiles of patients with imme-
diate food reactions to cereals, followed in a Food Allergy outpatient 
consultation.
Materials and methods: Ten patients (8 males) with an average age 
of 42 ± 12 years were included. We recorded the first food/drink con-
taining cereals associated with clinical manifestations of food allergy 
and screened potential co-factors involved in the reactions. Our inves-
tigation included the evaluation of symptoms after ingestion of other 
foods and related to inhalant allergens. Skin prick tests (SPT) to cereal 
flours, to inhalant allergens and to Pru p 3 were performed. We car-
ried out specific IgE (sIgE) determinations to cereal flours and to some 
components: Gluten, Tri a 19, Tri a 14, Pru p 3 and Pru p 4. We per-
formed additional SPT, prick-to-prick tests and sIgE in selected cases, 
depending on clinical history.
Results: Two patients described symptoms after drinking beer and 
other two after ingesting pizza. One patient referred wheezing after 
eating corn or bread when exercising. The remaining patients devel-
oped food reactions after eating meals containing mixed foods that 
always included cereals, particularly wheat. Nine patients had systemic 
reactions and severe anaphylaxis occurred in six of them. In the four 
patients with positive sIgE to Tri a 19, anaphylaxis only occurred asso-
ciated with exercise. However, two of them had recurrent urticaria 
while treated with low doses of aspirin. Four patients had sIgE to Tri 
a 14. Two of them described systemic reactions with variable sever-
ity and even anaphylaxis when co-factors such as exercise, alcohol or 
drug intake were present. One patient was only sensitised to gluten. 
All the patients sensitised to Tri a 14 had sIgE to Pru p 3. Besides cereal 
allergy, most of the patients had other food allergies. Seven patients 
had respiratory allergies related to inhalant allergens.
Conclusions: Cereal allergy diagnosis is a clinical challenge. Sensi-
tisation to Tri a 19 seems to be directly related to wheat- dependent 
exercise induced anaphylaxis, but for those positive to Tri a 14 other 
different components and co-factors may be crucial for clinical sever-
ity. CRD improved the accuracy of cereal allergy diagnosis, particularly 
wheat allergy.
Poster Session 6: Molecular diagnosis in prevention and therapy
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Background: Allergen immunotherapy is an effective treatment 
of allergic rhino-conjunctivitis. Clinical efficacy is associated with 
improvement of basophil sensitivity and an increase in allergen spe-
cific immunoglobulin concentration.
Objective: Can assessment of allergen component sIgE be used to 
diagnose clinically relevant allergic sensitizations?
Can pretreatment component specific sensitizations predict IgG4 
responses during updosing of AIT/SCIT?
Materials and methods: Twenty-four subjects with grass pollen 
allergic rhino-conjunctivitis were randomized 3:1 to receive AIT/SCIT 
(Alutard SQ) or to an open control group. sIgE and specific IgG4 con-
centrations were determined for eight grass pollen molecules and for 
additional sensitizations by ISAC before treatment and after updosing.
Results: The absence of pretreatment component sIgE had in general 
a good negative predictive value (58.3–100  %) for clinically relevant 
allergies reported by the patients in a standardized questionnaire, 
while sIgE sensitizations only predicted clinical relevant allergies to a 
lesser extent. sIgE against eight grass allergen molecules decreased 
from a median 4.6 ISU before treatment to 2.14 ISU (p  <  0.0001, 
n = 102) after updosing of AIT. The updosing phase induced a sIgG4 
increase from a median 0 ISU pretreatment to 0.83 ISU after updos-
ing (p  <  0.0001, n  =  102), but only for allergen molecules to which 
pretreatment sIgE was detected (Spearman’s σ  =  0.72, p  <  0.0001, 
n = 102).
Conclusions: Assessment of component resolved sIgE is useful to 
confirm or rule out clinical relevant allergies. Pretreatment allergen 
component sIgE appears to determine the induction of sIgG4 in the 
updosing phase, and may be useful to predict response to AIT.
Keywords: Molecular allergy; Grass pollen allergy; SCIT; Allergic 
rhino-conjunctivitis
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Background: Latex allergy affects mainly selected populations, called 
high-risk groups. Latex sensitization profile differs between these risk 
groups, but the existence of different profiles is not an aspect taken 
into consideration for the vaccine production. The commercially avail-
able immunotherapy extract is mostly constituted by Hev b 6 and Heb 
b 5 proteins. We aimed to describe the relevance of recombinant latex 
allergens for the specific immunotherapy’s decision and follow-up.
Materials and methods: We describe the clinical cases of 3 patients, 
who were successful desensitized with sublingual latex-immuno-
therapy (SLIT 100 % Latex, ALK-Abelló®). Before immunotherapy (T0) 
all patients were tested with skin prick tests to latex and foods with 
latex cross-reactivity responsible for latex-fruit syndrome (LFS), latex-
specific IgE (LsIgE) and single recombinant latex allergens panel (rHev 
b 1, rHev b 3, rHev b 5, rHev b 6.01, rHev b 8, rHev b 9 and rHev b 11). 
This evaluation was repeated after a course of immunotherapy with at 
least 3 years duration.
Results: Case 1: 41-year-old woman with history of 15 surgeries and 
latex-induced anaphylaxis (LIA) and LFS (anaphylaxis with banana 
and passion fruit). Laboratorial evaluation T0/after 44  months of 
SLIT was: LsIgE 17.2/1.04  kU/L, rHev b 1 0.36/<0.10  kU/L, rHev b 3 
<0.35 kU/L, rHev b 5 15.9/0.54 kU/L, rHev b 6.01 17.3/1.06 kU/L, rHev 
b 9 2.02/<0.10  kU/L, rHev b 11 1.36/0.97  kU/L. Symptomless inges-
tion of banana and only with rhinoconjunctivitis by accidental inha-
lation of latex. Case 2: 59-year-old man, surgeon, with LIA and LFS 
(anaphylaxis with avocado, banana and bell pepper). Laboratorial 
evaluation T0/after 42 months of SLIT: LsIgE 14.6/1.68 kU/L, rHev b 5 
1.94/<0.10 kU/L; rHev b 6.01 2.73/2.01 kU/L, rHev b 1, rHev b 3, rHev 
b 8, rHev b 9, rHev b 11 <0.10 kU/L. Without symptoms on accidental 
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latex contact and after chestnut and bell pepper ingestion. Case 3: 
43  year-old woman, nurse, with LIA. Laboratorial evaluation T0/after 
60  months of SLIT: LsIgE 10.5/<0.10  kU/L, rHev b 5 1.48/<0.10  kU/L; 
rHev b 6.01 1.20/<0.10 kU/L, rHev b 1, rHev b 3, rHev b 8, rHev b 9, rHev 
b 11 <0.10 kU/L. Asymptomatic latex contact.
Conclusions: Evaluation of latex sensitization profile should always be 
performed before latex immunotherapy’s decision. Recombinant latex 
allergens (rHev b 5 and rHev b 6.01) showed to be essential to decide 
latex immunotherapy, as well as to assess the achievement of a suc-
cessful desensitization.
Keywords: Latex allergy; Recombinant latex allergens; Immunotherapy
P52 
Omega‑5‑gliadin in the diagnosis of wheat‑dependent 
anaphylaxis induced by ibuprofen but not by exercise
Joana Cosme1, Letícia Pestana1, Amélia Spínola Santos1, Manuel Pereira 
Barbosa2  
1Immunoallergy Department ‑ Hospital de Santa Maria – Centro Hospi‑
talar Lisboa Norte, Lisbon, Portugal; Faculdade de Medicina de Lisboa, 
Lisbon, Portugal; 2Immunoallergy Department ‑ Hospital de Santa Maria – 
Centro Hospitalar Lisboa Norte, Lisbon, Portugal; Faculdade de Medicina 
de Lisboa; Faculdade de Medicina de Lisboa, Lisbon, Portugal
Correspondence: Joana Cosme
Clinical and Translational Allergy 2016, 6(Suppl 2):P52
Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) can 
enhance the symptoms of wheat-dependent exercise-induced ana-
phylaxis (WDEIA). Only a few reports of wheat-dependent anaphylaxis 
induced by the combination of wheat and NSAIDs without exercise 
have been made.
Materials and methods: Demonstrate the role of rTri a 19 (ω-5-
gliadin) in the diagnosis of wheat-dependent anaphylaxis induced by 
NSAIDs without exercise as a cofactor.
Results: Case report of 36 years-old man with allergic (mites) rhinosi-
nusitis, referred to our Immunoallergy department for an episode of 
generalized urticaria, itching, dyspnea and hypotension that was pre-
ceded, 30 minutes earlier, by the ingestion of wheat bread with butter 
followed by one ibuprofen tablet. By that time, he was in the eighth 
day of antibiotherapy with amoxicillin/clavulanic acid and in third 
day of ibuprofen—600  mg every 12hours, for a dental infection. The 
patient was admitted in the emergency department and the symp-
toms disappeared after administration of intramuscular adrenaline, 
intravenous antihistamines and corticosteroids. He refers no relation of 
this event with physical activity and had no previous complaints with 
wheat ingestion with or without associated exercise. SPT showed posi-
tive results to dust mite, shrimp, tropomyosin and wheat (wheal 4 mm) 
but negative to gliadin extract. Prick-prick reaction to wheat flour was 
positive (wheal 8 mm). The levels of serum total IgE was >2000 UI/mL 
and sIgE to wheat, gluten and rTri a 19 (ω-5-gliadin) were 4.67, 7.7 and 
21.60 KUA/L respectively. Using the ImmunoCAP ISAC (Thermo Fisher 
Scientific, Sweden) there were determined: rTri a 19 (ω-5-gliadin) of 9.2 
ISU-E and nFag e 2, rTri a 14 and nTri a aA_TI all negatives. Exercise chal-
lenge tests were performed without and with prior wheat ingestion 
were both negative. There were also performed an oral provocation 
test with meloxicam without wheat that was negative. The diagnosis 
of wheat-dependent anaphylaxis induced by NSAIDs was made and 
the patient was prescribed with an epinephrine auto-injector 0.3 mg. 
Recommendations to avoid taking NSAIDs 3 h before and after wheat 
ingestion were made.
Conclusions: NSAIDs are common triggers of WDEIA but its role as 
cofactor of wheat-dependent anaphylaxis is not well studied. We 
present a case of wheat-dependent anaphylaxis induced by NSAIDs 
where the determination of rTri a 19 (ω-5-gliadin) was an important 
toll in the diagnosis.
Keywords: RTri A 19; Omega-5-gliadin; Wheat, Anaphylaxis; Nonsteroi-
dal anti-inflammatory drugs
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Background: Provocation tests for food dependent exercise induced 
anaphylaxis (FDEIA) evaluation are not deprived of side effects and 
have a high rate of false negatives. This is particularly challenging in 
individuals sensitized to panallergens.
Aim: To assess IgE cross-reactivities using in-vitro depletion in patients 
sensitized to LTP with an history of FDEIA.
Materials and methods: Three patients with history of FDEIA, sensi-
tized to LTP were studied. A 25-year-old man, with cholinergic urticaria 
and mild oral allergy syndrome to peach, who suffered an episode of 
generalized urticaria and angioedema during a recreational soccer 
match, preceded by peach-based soft drink ingestion; a 19-year-old 
woman, sensitized to house dust mite and pollens with previous his-
tory of allergic rhinitis and controlled asthma, suffered an anaphylactic 
shock while playing soccer, having ingested walnuts in the previous 
90 min and a 57-year-old man with bakers-asthma with four episodes 
of anaphylaxis during exercise after ingesting wheat-containing food. 
All individuals performed diagnostic work-up with skin prick tests 
(SPTs) and specific IgE (sIgE) for baseline characterization and LTP 
sensitization confirmation. For in  vitro immune-depletion procedure, 
duplicate samples of each patient serum were pre-incubated with the 
suspected native allergen (peach, walnut or wheat, respectively) in a 
solid phase (ImmunoCAP®). The eluted serum, containing unbound 
IgE, was collected and samples were re-tested and compared using 
ImmunoCAP ISAC®.
Results: The first patient showed LTP sensitization to Prup-3, Cor-a-
8, Jug-r-3, Arah-9; after pre-incubation with peach there was 100  % 
depletion of sIgE to all LTPs. The second patient had SPTs and sIgE 
positive to Rosaceaes, non Rosaceae fruits and nuts, including mango, 
orange and walnuts; ISAC detected LTP sensitization (Prup-3, Cor-a-
8, Jug-r-3, Arah-9); walnut depleted sIgE by 60 % to Ara-h-9, 67 % to 
Prup-3 and Pla-a-3, 75 % to Artv3, 88 % to Jugr-3 and 100 % to Cor-a-8. 
The patient with previous baker-asthma, SPTs and sIgE were positive 
to wheat, although ω-5-gliadin was negative; ISAC showed sensiti-
zation to Prup-3, Jug-r-3, Arah-9, Tri-a-14; wheat immunodepletion 
occurred by 100 % only to Tri-a-14.
Conclusions: In-vitro immunodepletion may be an useful assay to 
guide the diagnostic study, deciding which allergens to test, and 
also eviction recommendations in patients with FDEIA sensitized to a 
panallergen like LTP.
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Background: In the south of Portugal, grass and olive tree are the 
most common pollen allergens. In a previous study in pollen polysen-
sitized patients, when comparing the results of SPT (skin prick tests) 
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and ISAC (ImmunoCAP-ISAC) we observed an excellent concord-
ance between the two tests for grass but not for olive pollen. The 
aim of this study was to characterize the pattern of sensitization to 
molecular allergens in patients with positive SPT to olive and pollen 
polysensitization.
Materials and methods: We did a retrospective analysis on a sample 
of 42 patients with asthma and/or rhinitis, with positive SPT to olive 
and at least one more pollen, who had specific IgE detection by ISAC. 
We analized the results of ISAC, focusing on olive pollen specific aller-
gens (Ole e 1, Ole e 7 and Ole e 9) and crossreactive allergens.
Results: Mean age was 22 years (ranging from 4 to 52 years) and 52 % 
were females. Besides olive, SPT was positive to grass in 95.2 %, plan-
tain in 45.2 %, birch in 35.9 %, plane tree in 35.9 % and to other pollens 
in less than 30 % each. In ISAC, 50 % (n = 21) were positive to Ole e 1 
and 7 % (n = 3) reacted to Ole e 7, corresponding to 22 olive positive 
patients (Olea+). No patient reacted to Ole e 9. Overall, 48 % (n = 20) 
had no detectable IgE to the olive pollen allergens present in ISAC 
(Olea−). We found co-sensitization to grass allergens in the majority 
of our sample: 82 % of Olea+ patients and 100 % of Olea− patients. 
Olea+ patients were sensitized to profillins and/or polcalcins in 36 % 
of cases; Olea− patients in 50 % of cases. We found no sensitization to 
any crossreactive allergen (profillins, polcalcins, PR-10 or LTP) in 41 % 
of Olea+ and in 45 % of Olea− patients. In this sample of 42 patients 
with positive SPT to olive pollen, ISAC detected no IgE, neither to olive 
species specific nor to crossreactive molecules in 21 % (n = 9).
Conclusions: In polysensitized patients, positive SPT in the absence 
of species specific molecules is attributed to the presence of sensitiza-
tion to panallergens and not to the allergen source. In our sample of 
patients apparently sensitized to olive the percentage of sensitization 
to olive species specific allergens was low and in almost half of these 
there was also no reactivity to panallergens which could explain the 
positive SPT. These results suggest that we might be missing, in ISAC, 
an olive species specific allergen rellevant to our population.
Keywords: Olive pollen; Mollecular allergens; Panallergens; Diagnosis
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Background: Alternaria alternata (Aa) has been considered a relevant 
allergen in airways atopic disease and specific immunotherapy may be 
indicated. Alt a 1 is the major allergen and immunotherapy extracts 
standardization is based on it. On the other hand sensitization to 
minor allergens may compromise the efficacy and/or the safety of the 
treatment. Our aim was to estimate the prevalence of Aa sensitization 
among atopic patients in Portugal, as well as compare the use of a 
total Aa extract to a purified Alt a 1 extract in the diagnosis.
Materials and methods: We performed skin prick tests in 102 con-
secutive patients referred to our outpatient allergy clinic using our 
standard battery of aeroallergen extracts and also included Aa total 
and Alt a 1 Diater® extracts. Papules with medium diameter 3 mm or 
more were considered as positive tests. We characterized Aa sensitive 
patients and analysed differences between Aa total and Alt a 1 results.
Results: Sixty patients had at least one positive test, thus being atopic. 
Twenty one (35  %) atopic patients were positive to Aa total extract 
and 17 (28 %) to Alt a 1 extract. Aa sensitive patients were 13 female, 
8 male, aged 7 to 66 years, mean 23.2 ± 16.0 and 43 % of them had 
asthma; Aa non-sensitive atopic patients were 15 female, 24 male, 
aged 2–64 years, mean 20.6 ± 17.0, 39 % having asthma. Relating Alt a 
1 to Aa results 13 patients showed differences between the two, vari-
ation of medium diameter of papules ranging from −100 to +50 %.
Conclusions: Prevalence of Aa sensitivity was fairly high in the studied 
group −35 %. We found no statistical significant differences between 
Aa sensitive versus non-sensitive patients concerning age, sex and 
pathologies. Seventeen (81 %) Aa sensitive patients had positive test 
to Alt a 1. Differences in skin prick test results between Aa and Alt a 1 
extracts support a frequent sensitivity to Aa minor allergens and point 
to the advantage of using purified Alt a 1 extracts in the diagnosis and 
in immunotherapy for Aa allergy.
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Background: Casein (Bos d8) is identified as major allergen in cow’s 
milk and in high levels often indicates allergy to both fresh and baked 
milk. It may be used to predict and aid the management of acute 
cow’s milk allergy in children, with low levels indicating a tolerance to 
baked milk products
Casein is a heat stable protein and the proteins remain stable even after 
120 mins boiling at 100 °C. This is unlike α-lactalbumin which disappears 
after 30 mins, β-lactoglobulin after 15 mins and Lactoferrin after 10 mins.
A large study suggested that 75 % of children with a recent diagnosis 
of cow’s milk protein allergy tolerated baked milk. Tolerance of baked 
milk is a good indicator for outgrowing allergy and with the addition 
of baked milk into the diet appears to accelerate tolerance. Although 
there is a paucity of published evidence to support the practice, home 
reintroduction of baked milk products has become routine practice 
through experience in allergy services in the UK. There are limited cut-
off levels for casein published in literature.
We have audited the use of casein spIgE in managing children with 
cows’ milk allergy in our UK based population.
Materials and methods: Casein spIgE testing was incorporated into our 
evaluation of children with cow’s milk allergy. Supervised baked milk chal-
lenges were performed on selected children using ‘malted milk’ biscuits.
Results
  • A total of 98 tests were requested over a period of 7 years.
  • 42 children with confirmed cows’ milk allergy were challenged.
  • 29 of them had eczema.
  • Their mean age was 4.7 years, median 3 years (Range 1–16 years).
  • SPT was performed to fresh and cows’ milk reagent (Diagenics)
  • 41 children passed and successfully introduced baked milk and 
remain symptom free with regular exposure.
  • 9 of these children have outgrown their milk allergy and tolerate 
fresh milk.
 • See Tables 5 and 6 of results
Table 5 Result values for  children passing baked milk 
challenge
Mean Median Range
Fresh Milk SPT 11.25 mm 10 mm 3–33 mm
Cow’s Milk reagents SPT 3.68 mm 3.04 mm 0–10.8 mm
SpIgE Cow’s milk 5.61 iu 2.80 iu 0–37.2 iu
SpIgE Casein 2.20 iu 0.55 iu 0.02–29.8 iu
Table 6 Casein values with  delayed reaction result 
excluded
Mean Median Range
SpIgE Casein 1.51 iu 0.53 iu 0.02–12.9 iu
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Conclusions: Low levels of casein specific IgE give a good indicator of 
outcome to challenge and aids early selection of patients for baked milk 
challenges. This is especially important in clinical settings with no on site 
intensive care where careful challenge risk stratification is important. 
Early inclusion of dietary baked milk accelerates the resolution of cows’ 
milk allergy and widens the choice of foods for these children.
The child with casein of 29.8 passed their in-hospital food challenge. 
When baked milk was introduced at home, she became symptomatic 
and currently remains milk free. Discarding this result we get the fol-
lowing results
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Background: Although double-blind placebo-controlled food chal-
lenge (DBPCFC) is established as the current “gold standard” for food 
allergy diagnosis, the criteria by which food challenge ingredients 
should be evaluated for suitability have not been standardised. Fur-
thermore, the amount of allergic material in food challenges should 
be comparable to commonly consumed materials. We aimed to char-
acterise the peanut flour in a DBPCFC with respect to peanut allergen 
content and IgE reactivity to determine suitability for use.
Materials and methods: Roasted peanut flour (four batches) and raw 
peanut flour were used. Sera from peanut allergic individuals were 
obtained from the Manchester Allergy and Respiratory Tissue Bank. 
Peanut flours were characterised using 2-dimensional (2D) SDS-PAGE, 
immunoblots, IgE immunoblots, IgE ELISA and mass spectrometry. The 
peanut flour-incurred challenge meal was used to determine its reac-
tivity with sera from allergic individuals.
Results: Peanut flour was characterised by immunoblotting to show 
the presence of the major allergens (Ara h 1, Ara h 2, Ara h 6 and Ara h 
3). Protein aggregation was observed in all the immunoblots as a con-
sequence of roasting (most prominent was aggregation of Ara h 1 and 
Ara h 3 acidic subunit). Allergens were profiled using untargeted mass 
spectrometry. IgE immunoblots and immunoassay using sera from 
allergic patients confirmed consistent patterns of reactivity of peanut 
flour between batches. The IgE immunoblots performed with extracts 
of the peanut-incurred dessert challenge meals demonstrated little or 
no difference in the reactivity compared to the roasted peanut flour 
itself.
Conclusions: Variation between batches of peanut flour with regards 
to peanut allergen profiles and IgE reactivity was minimal. IgE reactiv-
ity of peanut was maintained after being incurred into the chocolate 
dessert. These data show the suitability of the peanut flour as an active 
ingredient in oral food challenges.
Keywords: Peanut; Allergy; DBPCFC; IgE immunoreactivity
P58 
Specific IgE to recombinant allergens of hazelnut and oral food 
challenge in children
Gourdon Dubois Nelly1, Sellam Laetitia2, Pereira Bruno1, Michaud Elodie1, 
Messaoudi Khaled1, Evrard Bertrand1, Fauquert Jean‑Luc1  
1CHU, Clermont‑Ferrand, France; 2CH, Montlucon, France
Correspondence: Gourdon Dubois Nelly
Clinical and Translational Allergy 2016, 6(Suppl 2):P58
Background: Rationale: Oral Food challenge (OFC) is the milestone 
to access to a definitive diagnosis of hazelnut allergy (HA). We investi-
gated the relevance of Specific IgE to recombinants allergens of hazel-
nut available in daily practice.
Materials and methods: 31 children (20 M/11F) aged 10.5 ± 4.9 years, 
were recruited because referred to the allergy outpatient unit of the 
University Hospital Clermont-Ferrand, France, to practice OFC to 
hazelnut. All underwent a reaction after ingestion and were sensi-
tized to hazelnut (positive SPT or specific IgE measurements over 
0.10 IU/mL). Specific IgE dosages (ImmunoCAP Thermo Fisher®) were 
performed versus cor a1, cor a8, cor a9 and cor a14 and expressed in 
IU/mL (median, [Q25-Q75]). Single blind placebo controlled OFC was 
performed the same day according to usual recommendations, as well 
as skin prick-tests (SPT, positive when the wheel reached 3 mm) and 
IgE dosages to hazelnut. HA was assessed when an objective reaction 
occurred after OFC. Comparisons between the groups were performed 
using the Chi-square tests for categorical variables, and by the Student 
t-test or Kruskal–Wallis test for quantitative parameters.
Results: At baseline, groups with positive OFC (n = 8 OFC+) and nega-
tive OFC (n =  23 OFC−) were similar in terms of sex, age, and initial 
reaction. Specific IgE to hazelnuts recombinant fractions did not dif-
fer significantly for cor a1 (5.0 [1.1–18.2] v. 1.2 [0.1–14.2]), cor a8 (0.1 
[0.1–0.5] v. 0.1 [0.1–0.2]). Cor a9 specific IgE levels were significantly 
higher (p = 0.01) in OFC+ patients than in OFC− patients (0.9 [0.3–2.4] 
v. 0.1 [0.1–0.2]). Cor a14 levels were very significantly higher (p < 0.001) 
in OFC+ (5.4 [2.2–8.4]) patients than in OFC− patients (0.1 [0.1–0.1]). 
Specific IgE to hazelnut did not differ significantly in both groups: 3.4 
[2.0–20.7] in OFC+ patients, and 1.9 [0.9–11.1] in OFC− patients. SPT 
to hazelnut were positive in 7 of the 8 OFC+ patients (87.5 %) and 6 of 
the 23 OFC-patients (26.1 %) (p = 0.004) and the wheel of SPT larger in 
OFC+ population (9.0 [5.5–11.0]) than in OFC− population (0.5 [0.0–
4.0]) (p = 0.004).
Conclusions: We concluded to the interest in this population of spe-
cific IgE measurements to recombinant fractions cor a9 and cor a14 in 
addition to SPT in order to predict OFC results on children suspected 
of HA.
Keywords: Hazelnut; Oral food challenge; Recombinant fractions; Spe-
cific IgE
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Background: Reports that proteins are allergens are increasingly com-
mon in peer-reviewed journals, open access articles of varied review 
qualities or by automated computer annotation. The impact of report-
ing a protein as an allergen can have significant consequences related 
to diagnostic accuracy and food risk assessment processes. But there is 
no standard definition accepted for proof of allergenicity. How should 
we define allergens? Who should define a protein as an allergen? The 
intent of this discussion is to consider sources of information and defi-
nitions focuses on allergens causing IgE mediated hypersensitivities.
Materials and methods: Allergens are defined primarily based on IgE 
binding tests with proteins purified from allergenic sources, proteins 
produced as clones from allergenic sources or simply by computer 
sequence comparisons to those of known allergens. While clinical 
responses to the pure protein could prove that a protein is an allergen, 
such tests are never conducted due to ethical considerations or lack of 
appropriately identified, voluntary allergic subjects. Publications typi-
cally report predicted (cDNA) translated protein sequences or partially 
characterized determined amino acid sequences. Subjects are often 
declared as allergic or sensitized with little or no clinical symptoms 
reported and without background information related to responses 
to other allergenic sources. This brief review is intended to stimulate 
researcher’s efforts.
Results: Sources defining allergens have different criteria and pur-
poses. The WHO/IUIS database provides a nomenclature system with a 
short-hand name for allergenic proteins (genus, species and number), 
typically prior to publication, based on assurances from the submitter. 
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Criteria are that a minimal number of allergic subjects (typically 5), 
produce IgE that binds to the protein. The AllergenOnline.org data-
base expert panel reviews published information of IgE binding to the 
taxonomic-protein group with a minimal requirement of specific IgE 
binding with preference for demonstration of allergenic activity (skin 
prick test, basophil activation) for risk assessment. Sequence sources 
(NCBI/UniProt) are increasingly auto-annotated based on keywords or 
low identity matches. Cross-reactive carbohydrate determinants can 
skew results
Conclusions: The burden of proof is on you, the allergen researcher, to 
clearly report objective characteristics and results!
P60 
Cat allergy: relationship between clinical and molecular 
diagnostic
María Cecilia Martín Fernández De Basoa, Antón Fernández Ferreiro, Elena 
Rodríguez Plata  
University Hospital Nuestra Señora de Candelaria, Santa Cruz De Tenerife, 
Spain
Correspondence: María Cecilia Martín Fernández De Basoa
Clinical and Translational Allergy 2016, 6(Suppl 2):P60
Background: Allergy to cat is a frequent cause of rhinitis, asthma or 
contact urticaria. The prevalence of sensitization to different cat aller-
gens is not well known but it seems that different patterns of sensitiza-
tion to cat allergens in patients with cat allergy can help us to predict 
the severity and persistence of symptoms.
Materials and methods: We select 39 sensitized patients to cat (51 % 
female, median age 28  years). Specific IgE measurement to cat aller-
gens Fel d1, Fel d2 and Fel d4 was performed by microarray ISAC® 
(ThermoFisher Scientific, Sweden), a value >0.3 ISU was considered 
as positive. Skin prick test was performed with an ALK-Abelló extract 
(Denmark). Association of Specific IgE measurements and presence 
and type of rhinitis or asthma was studied . Statistical analysis was per-
formed using Fisher test and chisquared test.
Results: 95 % of patients had specific IgE to Fel d1, 10 % to Fel d2, 
and 10 % to Fel d4. 82 % were monosensitized to Fel d1, 3 % to Fel d2 
and 3 % to Fel d4. 75 % of sensitized patients to Fel d4 were also sen-
sitized to Fel d1. Fel d2 was associated with severity of rhinitis and 
asthma (p < 0.01, p < 0.01, respectively). Fel d4 was associated with 
presence of asthma symptoms (p  <  0.04). Direct contact with cats 
was associated both to persistence and severity of rhinitis (p < 0.01, 
p < 0.01, respectively). A positive skin prick test to cat was associated 
with rhinitis and asthma symptoms (p < 0.01, p < 0.01, respectively).
Conclusions: The relationship between clinical and molecular diag-
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Background: Although rabbits are common domestic pets, severe 
allergic reactions to rabbits at home are rarely reported. There are 
some cases of mild to moderate allergic rhinitis, conjunctivitis, pruri-
tus and/or asthma in laboratory animal caretakers with frequent expo-
sure. Moreover, few studies have evaluated the allergenic relationship 
between rabbits and other furry animals.
We present the case of a 52  year-old woman, who presented with 
anaphylaxis minutes after inhalant exposure to rabbits in September 
2013. She had a history of asthma and rhinitis. She worked as a cook 
since 1987 and some of her tasks involved, occasionally, preparing rab-
bit for meals, including skinning.
Materials and methods: Skin prick tests were positive to house 
dust mites and cat epithelium. Prick-to-prick test was positive to 
raw rabbit meat. ImmunoCAP® test revealed high values of total IgE 
(1072  kU/L) as well as specific IgE to rabbit epithelium (28.2  kU/L) 
and rabbit meat (14.4 kU/L). Sodium dodecye sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE) immunoblotting with extracts from 
rabbit (meat, epithelium, urine) and cat (epithelium, albumin) was 
performed.
Results: Two IgE-binding bands with molecular masses of 50–60 kDa 
were identified. SDS-PAGE immunoblotting-inhibition was carried out 
using cat epithelium extract as solid phase. All rabbit extracts assayed 
(meat, epithelium, urine) were able to induce a total IgE binding inhi-
bition as well as a sample of cat albumin.
Conclusions: Sensitization to cat albumin and rabbit proteins (50–
60  kDa) were detected, which were probably different isoforms of 
rabbit albumin. These results suggest that rabbit was probably the 
primary sensitizer, contrary to what was expected and highlight the 
importance of molecular diagnosis.
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Background: Allergy to dog is a frequent cause of rhinitis, asthma or 
contact urticaria. The prevalence of sensitization to different dog aller-
gens is not well known but it seems that different patterns of sensi-
tization to dog allergens in patients with dog allergy can help us to 
predict the severity and persistence of symptoms.
Materials and methods: We select 41 sensitized patients to dog (61 % 
female, median age 31 years). Specific IgE measurement to dog aller-
gens Can f1, Can f2, Can f3 and Can f5 was performed by microarray 
ISAC® (ThermoFisher Scientific, Sweden), a value >0.3 ISU was con-
sidered as positive. Skin prick test was performed with an ALK-Abelló 
extract (Denmark). Association of Specific IgE measurements and pres-
ence and type of rhinitis or asthma was studied. Statistical analysis was 
performed using Fisher test and chisquared test.
Results: 44  % of patients had specific IgE to Can f1, 17  % to Can f2, 
12 % to Can f3, and 66 % to Can f5. 20 % were monosensitized to Can 
f 1, 2 % to Can f2, 5 % to Can f3 and 44 % to Can f5. Can f1 was associ-
ated with persistent rhinitis (p 0.01), Can f3 with severity of rhinitis and 
asthma (p < 0.01, p 0.01, respectively), and Can f5 to both persistence 
and severity of rhinitis (p 0.02, p < 0.01, respectively). Sensitization to 
several allergens in patients (1, 2, 3 or 4) was associated with persis-
tent asthma or rhinitis (p 0.02, p 0.01, respectively), and with moder-
ate severity (p 0.04). Direct contact with dogs was associated with 
both, persistency and severity of rhinitis (p 0.02, p 0.03, respectively). 
The wheal diameters of skin test with commercial extract of dog were 
smaller in patients monosensitized to Can f 5.
Conclusions: The relationship between clinical and molecular diag-
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Background: Timothy grass (Phleum pratense) belongs to the Pooideae 
subfamily and it is one of the most significant source of grass pollen 
allergens in temperate regions.
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Materials and methods: We compared the levels of grass pollen-spe-
cific IgE measured in non-haemolytic, non-lipaemic, non-icteric serum 
samples from patients with genuine sensitization to Timothy grass pol-
len, evidenced in vitro by Poaceae family-specific IgE biomarker (beta-
expansin rPhl p 1) and/or Pooideae subfamily-specific IgE biomarker 
(ribonuclease rPhl p 5), using two immunoblot test systems: a blot line 
assay for IgE antibodies against eleven raw aeroallergen extracts and 
a multi-parameter test system for nine pollen single purified allergen 
components and two whole pollen allergen extracts. Both immuno-
blot test procedures are based on line blot system technology, with 
allergens in parallel lines at defined positions on membrane strips, 
and consist of three basic steps: serum incubation, enzyme conjugate 
(alkaline phosphatase-labelled anti-human IgE, monoclonal) incuba-
tion and chromogenic substrate (nitroblue tetrazolium chloride/5-
bromo-4-chloro-3-indolylphosphate) incubation.
Results: Twenty serum samples analyzed with the single purified aller-
gen components test kit revealed IgE sensitization to rPhl p 1 and rPhl 
p 5 in 60 % of cases, the rest presenting specific IgE only to rPhl p 1 
(35 %) or only to rPhl p 5 (5 %). The differences that we found between 
the values of Phleum pratense pollen-specific IgE determined with this 
multiparameter test system (47.38 ± 27.41 kU/L) and the values meas-
ured with the blot line inhalation test system (41.53 ± 28.26 kU/L) in all 
serum samples were not practically significant, and the enzyme aller-
gosorbent test/EAST class correlation was really acceptable.
Conclusions: In patients with suspected grass pollen allergy, the com-
ponent-resolved multiparameter immunoblot test system provides a 
reliable and costly efficient in vitro assessment of Timothy grass pollen-
specific IgE with a very good correlation with the measurement using 
the line blot test system with raw allergen extracts, besides allowing 
an in-depth characterisation of sensitization to disease-causing (Phl 
p1, Phl p5) and cross-reacting (Phl p 7, Phl p 12) allergen components 
from grass pollen on one test strip.
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Background: The “gold standard” of food allergy diagnosis is double 
blind placebo controlled food challenge. There has been little stand-
ardisation of challenge materials over the years and the EU labelling 
requirements specify for “fish” to be labelled rather than specific fishes. 
As part of a study on fish allergy standardised oral food challenge 
meals for the diagnosis of allergy to different fishes (cod, salmon and 
mackerel) have been developed.
Materials and methods: A set of powdered fish ingredients were 
obtained and assessed with regards protein profile and immunoreac-
tivity using an antibody specific for cod parvalbumin. Oral food chal-
lenge meals were developed based on those used in the EuroPrevall 
project using powdered cod, salmon and mackerel. Blinding was eval-
uated using trained sensory panellists (n = 9). The homogeneity and 
dose verification of the challenge meals were assessed using commer-
cially available ELISA kit utilising a cod parvalbumin antibody.
Results: Fish powder protein profiles were evaluated compared to 
samples of fish flesh. The content of parvalbumin evaluated and dem-
onstrated that mackerel had the lowest content and cod the highest 
content of parvalbumin allergen. The protein content of fish pow-
ders varied widely reflecting different fishes and manufacturing pro-
cedures. Once incorporated into the challenge matrix there was no 
noticeable variation between placebo and fish-containing challenges 
for salmon and cod. Blinding at a higher dose was not possible for the 
mackerel due to its’ strong characteristics and lower protein content.
Conclusions: Challenge meals can be prepared for a range of fishes 
but quality of blinding is dependent on access to quality powdered 
fish ingredients with a high protein content. Parvalbumin content of 
fish powders was ranked cod  >  salmon  >  mackerel suggesting that 
both IgE-reactivity determined in vitro and clinical reactivity would be 
lower for mackerel than cod challenges. Further studies in  vitro and 
in vivo will test this proposition.
Keywords: Fish double blind placebo controlled food challenge
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Background: Fish and peanut allergies are among the most danger-
ous food allergies. Symptoms occur by allergen exposure via gastroin-
testinal or respiratory tracts. Food matrix components may contribute 
to the immune response. We explored interactions of intestinal and 
bronchial epithelial cells with the major Atlantic cod allergen Gad m 
1, or a peanut allergen Ara h 1, with or without codfish-derived food 
matrix or peanut lipids.
Materials and methods: Caco-2 and 16HBE14o- cells were used as in 
vitro models for human intestinal and bronchial epithelial cells, respec-
tively. To explore the type of interaction between the allergens and the 
cells, confluent cells were treated with fluorescently labelled Gad m 1 
with or without codfish matrix, or with Ara h 1 with or without peanut 
lipids. Labelled allergens were detected by confocal microscopy. To 
explore cytokine and chemokine gene expression in treated cells, total 
RNA was isolated and mRNA levels of CCL20, MCP-1, TSLP, IL-6 and IL-8 
were determined by qRT-PCR.
Results: In Caco-2 cells, both allergens bound to the apical plasma 
membrane. In 16HBE14o- cells, Gad m 1 localized to the lateral mem-
brane domain (bellow ZO-1 level), while Ara h 1 interacted with the 
apical and lateral (above ZO-1 level) membrane domains. Co-treat-
ment with Ara h 1 and peanut lipids reduced the fluorescent Ara h 
1 signal in 16HBE14o-cells. In both cell lines, treatments with the 
allergens and codfish matrix/peanut lipids induced differential gene 
expression of cytokines and chemokines. Both allergens when applied 
alone reduced CCL20 mRNA levels in Caco-2 cells by 25 % and mRNA 
levels of all the explored genes in 16HBE14o-cells by 30–70 %. Gad m 
1 also decreased MCP-1 gene expression in Caco-2 cells by 30 %. Cod-
fish matrix increased IL-6 mRNA levels in both cell lines by 1.6–3-fold. 
Peanut lipids decreased MCP-1 mRNA levels by 20  % in Caco-2 cells 
and by 30 % in 16HBE14o-cells. TSLP mRNA levels were increased by 
all treatments in Caco-2 cells (1.5–2.5-fold), while in 16HBE14o- cells all 
the treatments downregulated TSLP gene expression by 1.5–2.5-fold.
Conclusions: Fish and peanut allergens interact with plasma mem-
branes of intestinal and bronchial epithelial cells, but are not internal-
ized. This interaction induces signalling in the cells, which is further 
modulated by food matrix components and may contribute to allergic 
sensitization and reaction.
Supported by the Austrian Science Fund grants SFB 4608 and 4613 
and the doctoral program W1248-B1.
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Background: Interleukin 4 is an inflammatory cytokine that initi-
ate conversion of T cells towards Th2 population and IgE production 
specific for allergy and asthma. It also stimulates monocytes and 
macrophages to produce other pro-inflammatory cytokines thus 
enhancing inflammation. Recent studies showed that IL-4 influences 
metabolism of adipocytes indicating the relationship between allergic 
inflammation and obesity.
The aim of this study was to investigate the effect of IL-4 exposure on 
the metabolism of rat adipocytes and the expression of pro-inflamma-
tory factors in these cells.
Materials and methods: Adipocytes were isolated from epididymal 
fat pad. After isolation, adipocytes were incubated with IL-4 at differ-
ent doses (1, 10, 100 nM) for 2 h. After incubation, lipogenesis (both 
basal and insulin-stimulated) and lipolysis (basal and isoproterenol-
stimulated) were measured. Perilipin, GLUT4 and phosphorylation of 
HSL were measured by Western blot following 8 h of incubation with 
IL-4. Pro-inflammatory (leptin, resistin) and anti-inflammatory (adi-
ponectin) hormones concentration was measured in cell medium 
using ELISA kits. Gene expression of Tnfα, Crp, IL-6 and IL-4R was meas-
ured by real-time PCR.
Results: Incubation with IL-4 resulted in increased basal lipogenesis 
and decreased isoproterenol-stimulated lipolysis in rat adipocytes. We 
also observed significant increase of GLUT4 and decrease of phospho-
HSL protein levels. Expression of perilipin decreased however, this 
change was not significant. Moreover, we found increased concentra-
tion of leptin and resistin and decreased concentration of adiponectin 
in cell medium. Gene expression analysis showed increased expression 
for all studied factors.
Conclusions: Results obtained in our study indicate that IL-4 may play 
a role in increased fat deposition and represents a link between obe-
sity and other inflammatory conditions such as asthma.
The study was supported by the Polish National Science Centre, grant 
no. 2011/01/D/NZ5/02771.
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Background: Exposure to ozone, which is a major component of air 
pollution, induces a form of asthma that occurs in the absence of 
adaptive immunity. Although ozone-induced asthma is characterized 
by airway neutrophilia, and not eosinophilia, it is nevertheless associ-
ated with airway hyperreactivity (AHR), which is a cardinal feature of 
asthma. Programmed death-1 (PD-1) with its ligands, programmed 
death ligand B7DC (PD-L2) and was shown to regulate T-cell activation 
and tolerance. PD-1 has been characterized as a negative regulator 
of conventional CD4+ T cells. Recent studies have demonstrated that 
PD-L2 have important roles in modulating and polarizing T-cell func-
tions in allergen induced AHR
Materials and methods: Airway inflammation and AHR was meas-
ured in mice 24 h after the final ozone exposure. Mice was divided 4 
groups; 1. Air exposure BALB/c (WT air), 2. Air-PDL2−/− mice (PDL2KO 
air), 3. ozone exposure BALB/c (WT O3), and 4. Ozone-PDL2−/− mice 
(PDL2KO O3) on day 6. Mice were placed awake in individual wire mesh 
cages inside a stainless steel and Plexiglas exposure chamber and 
exposed to ozone (1 ppm) for 3 h on day 1, day 3 and day 5. For room 
air exposure, a separate and identical exposure chamber was used. 
Results: The severity of AHR and airway inflammation is significantly 
reduced in PDL2KO O3 group of mice compared with WT O3 group of mice. 
Conclusions: This study indicate that PD-L2 have important roles in 
the regulation of ozone-induced AHR and airway inflammation as well 
as allergen-induced AHR and airway inflammation
Keywords: Ozone; Airway hyperreactivity; PDL2−/− mice
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Background: Activated Th2 cells and eosinophils are hallmarks of the 
allergic inflammation in allergic rhinitis. However, which cells activate 
and attract T cells and eosinophils to the inflammatory lesion has 
not been determined. The aim of this study was to assess the role of 
mucosal mononuclear phagocytes, consisting of monocytes, mac-
rophages and dendritic cells, in the local allergic inflammatory reaction.
Materials and methods: Allergic rhinitis patients and non-atopic con-
trols were challenged with pollen extract and nasal symptoms were 
recorded. Mucosal biopsies, obtained at different time points before 
and after challenge, were used for immunostaining in  situ and flow-
cytometric cell sorting. Sorted mononuclear phagocytes were sub-
jected to RNA extraction and gene expression profiling.
Results: In an in vivo model of allergic rhinitis we found that CD14+ 
monocytes were recruited to the nasal mucosa within hours after local 
allergen-challenge, whereas conventional dendritic cells accumulated 
after several days of continued provocation. On the other hand the 
number of resident macrophages and plasmacytoid dendritic cells 
remained unchanged the first hours after allergen challenge. Tran-
scriptomic profiling of mucosal mononuclear phagocytes sorted after 
one week of continued allergen-provocation showed an activated 
phenotype, at least partially driven by IL-4 and/or IL-13 signalling. 
Importantly, gene expression of several Th2-related chemokines was 
significantly upregulated by the mononuclear phagocyte population 
concomitant with an increased recruitment of CD4+ T-cells and eosin-
ophils. Moreover the number of mucosal GATA3+ T cells increased 
48 h after allergen dose compared to baseline.
Conclusions: Our findings suggest that the mononuclear phagocyte 
population is directly involved in the production of proinflammatory 
chemokines that attract other immune cells. Rapid recruitment of 
CD14+ monocytes to the challenged site indicates that these proin-
flammatory mononuclear phagocytes have a central role in orchestrat-
ing the allergic inflammation locally.
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Background: Neuroimmunologic factors are important in the patho-
genesis and the course of allergic diseases such as allergic rhinitis 
and atopic dermatitis. Neuropeptides and neurotrophins released in 
the airways and skin upon allergic response also mediate neurogenic 
inflammation, thus modifying disease symptoms and severity.
Therefore, we investigated if neurogenic inflammation genes are 
involved in the pathogenesis of allergic diseases (atopic dermatitis, 
allergic rhinitis) in paediatric population.
Materials and methods: In the analysis we included 23 patients, 
11 patients with AR and 12 patients with AD aged between 6 and 
18 years. Diagnosis of allergic AR was made according to ARIA guide-
lines and AD was diagnosed based on diagnostic criteria defined by 
the American Academy of Dermatology. Diagnosis was made at least 
6  months before inclusion in the study. The control group consisted 
of 21 healthy children without past and current symptoms of allergy 
and asthma. The expression of 31 genes associated with neurogenic 
inflammation from peripheral blood leukocytes was analyzed with use 
of TaqMan Low Density Array method. As an endogenous control we 
used an assay specific for 18S rRNA gene. The target genes involved 
neurotrophins and their receptors, tyrosine kinases, neuropeptides, 
histamine metabolism pathway, neurokines and receptors of ion 
channels.
Results: In allergic patients we observed significant increase in expres-
sion of genes encoding two histamine metabolizing enzymes (HNMT, 
ABP1) as compared to the healthy children. For atopic dermatitis signif-
icantly increased expression was found for ABP1 (RQ = 35, p = 0.037) 
and HNMT (RQ  =  8.5, p  =  0.041), for allergic rhinitis patients we 
observed increased expression of ABP1 (RQ = 26.4, p = 0.043). Moreo-
ver, when comparing AD to AR patients, we found that expression of 
3 genes was increased in AR (IL4Ra, MAPK1, MME) as compared to AD, 
but the difference was not statistically significant.
Conclusions: Increased expression of histamine metabolizing 
enzymes (HNMT, ABP1) in allergic diseases (AR, AD) suggest that induc-
tion of histamine metabolizing enzymes might be an important con-
trol mechanism for the inflammation induced by histamine during 
allergic inflammation.
The study was supported by the Polish National Science Centre, grant 
no. 2011/01/D/NZ5/02771.
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Background: IgE is a mechanistically and structurally outstanding iso-
type and carries a pronounced glycosylation. Most glycans are of com-
plex type, only one glycan is an oligomannosidic structure. Mutational 
analyses have shown that the oligomannosidic glycan is indispensa-
ble for activity. The role of the complex type glycans however remains 
unclear.
Materials and methods: In order to engineer the glycosylation of 
human IgE we established the recombinant production of IgE in insect 
cells that do not attach complex type glycans. IgE Fc variants were pro-
duced in mammalian cells. The proteins were purified via affinity chro-
matography and characterised by ELISA, immunoblotting and SPR. 
RBL assays were used to prove biological function and the glycosyla-
tion was assessed by mass spectrometry.
Results: Upon expression in Sf9 insect cells recombinant human IgE 
(rIgE) was efficiently assembled and secreted into culture supernatant 
with yields of >30  mg/L. The rIgE exhibited a highly specific interac-
tion with its antigen, anti-IgE antibodies and IgE receptors. Glycoprot-
eomic analysis revealed the presence of a prototypic oligomannosidic 
N-glycosylation at several positions of the epsilon heavy chain. Com-
plex type glycans were not found. While mutation of the oligoman-
nose structure in the IgE Fc broadly abrogated effector cell activation 
mediator release assays demonstrated a biological activity of the gly-
comodified IgE comparable to that of IgE containing complex type 
glycans.
Conclusions: In summary the engineering of IgE with a fully oli-
gomannosidic glycosylation does not affect the molecular charac-
teristics as high affinity receptor and antigen binding and biological 
activity. Our data will contribute to the understanding and potential 
use of this important antibody isotype.
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Background: Science communication is an integral part of modern 
research and has been since more than a decade an important activ-
ity of the allergology research teams in Salzburg. The Flying Labs are 
one of these initiatives. Within this concept, we are able to bring a 
molecular biology lab into a school setting where, according to well-
established protocols, high-school students can perform experimental 
work directly in the classroom using up to date equipment. The course 
schedule is designed in way that the students themselves can elabo-
rate simple research questions, which are usually inspired by their eve-
ryday life. Besides a gene-analysis-lab, since 2009, a special Flying Lab 
has been dedicated to immunological and allergy-related topics.
Materials and methods: The Sparkling Science Project Bio KoSMoS 
(www.biokosmos.org), funded by the Austrian Ministry of Science, 
Research, and Economy (BMWFW), allowed us to further develop the 
Flying lab initiative and to test educational concepts such as “open 
innovation”, mentoring systems, and “citizen science”.
Results: We elaborated a novel course in which students get basic 
knowledge and experimental training in recombinant protein produc-
tion at their schools, using fluorescent proteins as models. These stu-
dents were invited to participate in “science days” at the University of 
Salzburg for additional training in basic techniques such as SDS-PAGE 
and Western blots with allergens. After this initial training program, we 
tested a cell-free expression platform for allergenic molecules and first 
experiments together with the students were already performed.
Conclusions: We demonstrated that initiatives such as Flying Labs 
can be used to successfully transfer modern science ideas and prin-
ciples to schools. In order to contribute to scientific questions, inter-
ested individuals, i.e. high school students, need to acquire a certain 
level of know-how and training. Thereafter, scientific questions can be 
addressed in a truly collaborative manner. We are convinced that this 
open innovation initiative will not only inspire young people to think 
and work scientifically, but will also help researchers to establish new 
methods for allergen expression and analysis.
The work was supported by the Sparkling Science project SPA 05-193 
and the priority program of the University of Salzburg (Allergy-Cancer-
BioNano Research Centre).
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Background: The target molecule of antihistamines is histamine H1 
receptor. However, pathological mechanism targeted by antihista-
mines remains to be elucidated.
Materials and methods: Histamine H1 receptor mRNA was deter-
mined by real-time quantitative RT-PCR. Activation of protein kinase 
C-delta (PKCδ) was assessed by immunoblot analysis. Nasal hypersen-
sitivity model rats sensitized with toluene 2,4-diisocyanate sensitized 
(TDI) were used. Nasal symptoms were scored by sneezing, rhinorrhea 
and nasal swelling. Clinical study was approved by the Ethical Commit-
tees of Tokushima Universith Hospital.
Results: The stimulation of H1 receptors up-regulated the level of 
histamine H1 receptors, consequently the H1 receptor mediated sig-
nalling propagated. The stimulation of H1 receptors phosphorylated 
protein kinase C-delta (PKCδ) and rottlerin, an inhibitor of PKCδ, sup-
pressed H1 receptor gene expression. A positive correlation between 
nasal symptoms with sneezing and rhinorrhea, and the level of hista-
mine H1 receptor mRNA was observed in the nasal mucosa of pollino-
sis patients. Antihistamines improved both nasal symptoms and the 
elevated level of H1 receptor mRNA either in the pollinosis patients or 
in the nasal hypersensitivity model rats.
Kujin is an anti-allergic Kampo medicine. Similar to antihistamines, 
Kujin extract improved both nasal symptoms and the elevated level 
of H1 receptor mRNA in nasal hypersensitivity model rats. (−)Maacki-
ain was isolated from Kujin extract. (−)Maackiain suppressed hista-
mine- or PMA-induced PKCδ phosphorylation. Heat-shock protein 90 
(Hsp90) was reported to form a complex with PKCδ and (−)maackiain 
disrupted the complex. Hsp90 inhibitors suppressed histamine H1 
receptor gene expression and improved nasal symptoms in allergic 
model rats.
Conclusions: Proliferation of histamine H1 receptor mediated signal-
ling was thought to worsen allergic symptoms. All these data sug-
gested that histamine H1 receptor gene is an allergic disease-sensitive 
gene, and antihistamines as well as Kujin improve symptoms by sup-
pressing H1 receptor-mediated gene expression signalling at different 
steps.
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